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ABSTRACT 
Coagulation factor VII in elderly people: genetic disposition and diet 
PhD thesis by Louise I. Mennen, Division of Human Nutrition and Epidemiology 
Wageningen Agricultural University, The Netherlands. September 17, 1997 
In elderly people an increase in thrombotic tendency may lead to a increase in the risk of 
a coronary event. Coagulation factor VII affects this thrombotic tendency and has been 
recognised as a risk indicator for coronary heart disease. It is not known whether the level 
of factor VII can be influenced at older age. From studies in young subjects it is clear that 
dietary fat and the R/Q353 polymorphism (alleles R and Q) are the main determinants of 
factor VII. We studied the relation of factor VII with diet in elderly men and women, 
taking the R/Q353 polymorphism into account. 
In a cross-sectional study among 1158 elderly men and women (>55 y) factor VII 
coagulant activity (FVII:C) and total factor VII (FVIIt) were investigated in relation to 
serum-triglycerides, the R/Q353 polymorphism and the habitual diet. FVII:C was inversely 
associated with dietary fibre and protein and positively with saturated fat intake and 
serum-triglycerides. These associations were much stronger in subjects with the RR 
genotype compared to those carrying the Q allele; if the mean intake of dietary fibre 
would increase with 10 g a day, FVILC would be expected to decrease with 7.6 % in 
elderly people homozygous for the R allele versus only 1.9% decrease in those carrying 
the Q allele. FVIIt was inversely related to intake of dietary fibre and positively to serum-
triglycerides, again the associations being stronger in subjects with the RR genotype. 
In a cross-over study among elderly women (> 60 y, 35 RQ/QQ, 56RR) the postprandial 
response of activated factor VII (FVIIa) to several fat-rich (50 g) breakfasts was evaluated. 
The response of FVIIa was very similar for meals rich in palmitic acid, rich in stearic acid 
or rich in linoleic/linolenic acid with a ratio of 3:1 or 15:1. The increase in FVIIa ranged 
from 14.9 (95% CI: 10.6,19.2) IU/mL after the stearic rich breakfast to 21.1 (16.6,25.6) 
IU/mL after the linoleic/linolenic 15:1 rich breakfasts. After the fat-free control breakfast 
FVIIa decreased with 8.7 (6.3,11.1) IU/mL. The mean absolute total response to the fat-
rich breakfasts combined was 37 IU/mL in subjects with the RR genotype and 16.1 IU/mL 
in subjects carrying the Q allele. Also the response relative to the fasting FVIIa level 
differed significantly between the genotype groups (RR: 42%, RQ/QQ: 32%). Serum-
triglycerides concentration was not associated with FVIIa. 
In elderly people, factor VII is influenced by dietary fibre, total dietary fat and serum-
triglycerides and not by fat type. The R/Q353 polymorphism strongly modifies these 
effects. This indicates that an increase in dietary fibre and a decrease in dietary fat intake 
may reduce the risk of a coronary event by reducing the level of factor VII, particularly in 
elderly people with the RR genotype. 
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General introduction 
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Chapter 1 
Coagulation cascade 
Haemostasis is a defense mechanism that serves to protect the integrity of the vascular 
system after injury of the endothelium of the vessel wall. The haemostatic process consists 
of platelet activation, blood coagulation and fibrinolysis. This system is normally quiescent 
but becomes active within seconds after injury. Together with platelet activation, triggering 
of the coagulation system results in the formation of a blood clot and occlusion of the 
injured site. The fibrinolytic system dissolves the haemostatic plug in the course of vessel 
healing and repair. 
If the balance between coagulation and fibrinolysis is disturbed, extensive clot formation 
can take place, which may influence the development of cardiovascular disease1"4. The 
coagulation system is a sequential activation of certain plasma proteases (proenzymes) to 
their enzyme forms. This cascade of activation reactions will finally lead to the formation 
of fibrin. The coagulation system as such will be clarified in detail below, but for reason 
of simplicity not all inhibitors or external factors influencing the cascade are described. 
After injury, blood coagulation is activated by the release of tissue factor from the vessel 
wall (Figure 1.1). Tissue factor binds to factor VII and forms a complex with it. If factor 
VII is activated it will activate factor X to Xa and factor IX to IXa. Factor IXa will form 
a complex with factor Villa and this complex is a second activator of factor X5. 
The protease responsible for the initial activation of factor VII is unknown, but once 
clotting is activated, several proteases further along the pathway, like factor Xa and IXa, 
can in turn activate factor VII. This will lead to an acceleration of the factor VII 
activation. Although factor Vila is able to activate factor X, the activation of factor X by 
IXa is the main route, since the factor Vila/tissue factor complex will be rapidly inhibited 
by tissue factor pathway inhibitor (TFPI). Once thrombin is formed the activation of factor 
XI is catalyzed. Once factor XIa is generated, there is an additional mechanism for 
augmenting the activation of factor IX, which makes the factor Vll/tissue factor complex 
at that moment redundant for the activation of factor X. 
Factor Xa in complex with factor Va activates prothrombin into thrombin (factor Ila). 
Thrombin cleaves fibrinogen into monomeric fibrin, which then polymerizes to form the 
fibrin clot. This whole process takes place on different cell-surface membranes, which play 
an important role in the formation of several complexes5. 
In short the tissue factor/factor VII complex is needed to activate factor X and start the 
initial generation of thrombin, after which the activation of factor IX and factor XI will 
result in an explosive formation of fibrin. 
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Figure 1.1. The coagulation cascade 
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Factor VII 
Factor VII is one of the coagulation factors found to be associated with cardiovascular 
disease2'6. Two prospective studies have shown that factor VII is higher in persons who 
died from coronary heart disease than in persons without the disease2,6. It is conceivable 
that a small increase of FVIIa may lead to an extensive formation of fibrin and thereby 
increase the chance of a vessel occlusion after rupture of an atherosclerotic plaque. 
To increase understanding of the behaviour of factor VII in relation to its determinants 
some biochemical aspects of factor VII will be described. 
Factor VII is a single-chain glycoprotein, with a molecular weight of approximately 
50,0007. This mature protein is composed of 406 amino acids8. It is a vitamin K dependent 
coagulation factor and has a high degree of homology with factor II, IX, X, protein C and 
protein S. It is synthesized by the liver and secreted into the blood as an inactive 
zymogen. It has the most rapid turnover rate of any coagulation factor, with a half-life of 
2 to 7 hours after activation7. The single chain form of factor VII as found in plasma 
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becomes activated (factor Vila) after enzymatic cleavage and has a 60- to 80-fold 
increased coagulant activity7. Cleavage can be performed by factor Xa, factor Xlla, factor 
IXa and thrombin8"10. This happens normally when the vessel wall is damaged and tissue 
factor is released, but also cold storage and contact activation with glass can activate 
factor VII zymogen7. In each case, a single Arg 152 - He 153 internal bond is cleaved, 
which results in the formation of a two-chain active enzyme composed of a light chain 
and a heavy chain held together by a disulphide bond. 
About 1% of the total amount of factor VII in the circulation exists as activated factor 
VII, the other part exists as the inactive factor VII zymogen. Several methods are available 
to measure factor VII. The activated part of factor VII can be measured directly (factor 
Vila), but also the coagulant activity of factor VII (factor VII:C) can be analyzed. 
Furthermore two methods exist to measure the total amount of factor VII (factor Vllt) in 
plasma. These methods will be described in more detail in Chapter 2. 
Determinants of factor VII 
Factor VII increases with age and with use of oral anticonceptives or hormone 
replacement therapy. It is positively associated with body mass index and is higher in 
women than in men especially after menopausal age""14. Furthermore, factor VII was 
found to be associated with blood pressure, alcohol intake, smoking, physical exercise and 
intake of caffeine"'215"18, but these findings are not consistent. The major known 
determinants of factor VII, however, are diet, blood lipids and genetic factors19"23. 
One cross-sectional study among rural Finnish men showed a positive correlation of total 
fat intake and fasting factor VII24. Results from intervention studies show that factor VII 
increases when the intake of dietary fat increases. This effect is seen in long-term studies 
on fasting factor VII as well as in short-term studies on postprandial factor VII level192025-
32
. The effect of the fatty acid composition of the diet used in these intervention studies is 
not quite clear. In some studies a difference in factor VII between diets which differ in 
fatty acid composition was found, while this is not the case in other studies20'25,28,29'32. 
These studies will be extensively described in Chapter 2. 
Other dietary factors which may influence factor VII are dietary fibre and protein. Factor 
VII was found to be inversely related to dietary fibre and positively to protein33"36, but 
clear evidence is missing. 
In many cross-sectional studies a positive association between serum-triglycerides and 
factor VII has been observed16,37"43. This relation is much less apparent in intervention 
studies on the effect of dietary fat on factor VII in which triglyceride concentration is 
14 
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measured as an intermediating factor'9,20'25"27. 
The R/Q353 polymorphism in the gene coding for factor VII is the result of a single base 
change in the codon for amino acid 353 and leads to the replacement of arginine (R) by 
glutamine (Q)23. The Q allele is associated with lower levels of factor VII. 
The combined effect of diet and genetic factors was investigated in a very small 
intervention study among coronary heart disease patients'06. It was found that the response 
of factor VII on a high-fat meal was much higher in patients with the RR genotype 
compared to those with the RQ genotype. This suggests that the R/Q353 polymorphism 
may modify the relation of factor VII with diet and blood lipids, but there is no extensive 
evidence for this hypothesis. 
Rationale and outline of this thesis 
Arterial thrombosis becomes more important in elderly people, since they have a high 
prevalence of atherosclerosis. Elevated levels of factor VII, in combination with the 
existing atherosclerosis, may increase their risk of a coronary event. However, no 
information on factor VII in elderly is available and it is not known whether in elderly 
people factor VII can be altered by diet. Therefore, we studied factor VII in relation to its 
major determinants in elderly people. 
A cross-sectional study and an intervention study were performed to answer the following 
questions: 
la. What is the magnitude of the association of factor VII :C and factor VII t with diet and 
serum-triglycerides in elderly men and women? 
b. Do these associations vary across genotype groups of the R/Q353 polymorphism? 
2a. Is, in elderly women, the response of factor Vila on a fat-rich meal dependent on the 
fatty acid composition of the meal? 
b. Do these responses vary across the genotype groups of the R/Q353 polymorphism? 
This thesis describes the results of a cross-sectional and an intervention study. To give 
background information on the relation of factor VII with dietary fat, the next chapter 
describes the state of the art on this topic at the start of the project. In Chapter 3 a cross-
sectional study on the relation of factor VII with diet in a large population of elderly 
people is evaluated. The effects of the R/Q353 polymorphism on the association of factor 
VII with diet and blood lipids in subjects from the extreme quintiles of the factor VII 
distribution are described in Chapter 4 and 5. Finally the postprandial effect of a fat-rich 
meal on factor VII was investigated in a randomized cross-over trial in a large group of 
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elderly women. This study is described in Chapters 6 and 7. A general discussion on 
factor VII, dietary fat and genetic disposition can be found in Chapter 8. 
16 
CHAPTER 2 
Coagulation factor VII, dietary fat and blood lipids: a review 
L.I. Mermen, E.G. Schouten, D.E. Grobbee, C. Kluft 
Thromb Haemost 1996;76:492-499 
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Introduction 
There is considerable, though inconclusive evidence, which suggests that coagulation 
factor VII is a risk indicator for cardiovascular disease. In the prospective Northwick Park 
Heart Study (NPHS) high levels of factor VII coagulant activity (FVII:C) were associated 
with an increased risk of ischaemic heart disease, which was stronger than the association 
between high levels of cholesterol and ischaemic heart disease1. Later this association was 
found to be confined to fatal events only6. Another prospective study (PROCAM) found a 
trend towards higher FVII:C values when only fatal events were taken into account2. 
Differences in measurement technique may explain the stronger association in the NPHS 
compared to the PROCAM study. In both studies a one-stage clotting assay was used, but 
with different factor VH-deficient substrate plasma's. When activated factor VII (FVIIa) 
concentrations were determined directly, the correlation between FVILC and FVIIa was 
considerably greater for the NPHS assay than for the PROCAM assay. If the thrombotic 
response is determined by the circulating concentration of FVIIa, then the NPHS assay 
seems to be more specific for investigating the relation between factor VII and 
cardiovascular disease44. A second explanation for the stronger association in the NPHS 
might be the practice of the NPHS of obtaining blood samples in the non-fasting state, 
with the possibility of increases in FVIIa28. In the PROCAM study, samples were obtained 
from fasting individuals. 
Also, some cross-sectional studies were carried out to investigate the association between 
factor VII and cardiovascular disease. In several studies patients with prior infarction had 
significantly elevated levels of FVILC compared with patients without such a history45"48. 
The Atherosclerosis Risk in Communities Study (ARIC) showed significantly higher 
FVILC in women with cardiovascular disease, but not in men45. Total factor VII (FVIIt) 
was elevated in first degree relatives of patients with premature ischemic heart disease 
compared to age-matched subjects without known risk factors49. Furthermore, patients with 
coronary artery disease and patients at high risk for this disease had higher levels of FVIIt 
compared to controls50,51. Finally, patients aged 45-64 years with thickened carotid arterial 
wall had a higher FVILC52, which was not observed in younger patients53. 
With a view to prevention of cardiovascular disease knowledge of the determinants that 
influence the known risk indicators is important. For factor VII the most important 
determinants seem to be genotype, age, gender, insulin resistance, body mass index, 
dietary fat and blood lipids"'12'19'20'23-54"59. Of these, dietary fat and blood lipids are subject 
to change and potential candidates for lowering the level of factor VII. To summarize 
current evidence with respect to dietary influence on factor VII, in this paper recent 
studies on factor VII, dietary fat and blood lipids will be reviewed. In order to make the 
Review 
article more comprehensible, the available methods for measurement of factor VII will be 
described first, after which some attention will be paid to the mechanisms underlying the 
relation between factor VII and dietary fat and blood lipids. A distinction between acute 
and chronic effects of dietary fat is made, as the underlying mechanisms for these effects 
may be different. The acute effects are described for postprandial factor VII levels 
(measured in blood samples collected in the non-fasting state) and the chronic effects are 
described for the fasting factor VII levels (measured in blood samples collected in the 
fasting state). 
Measurement of factor VII 
In the circulation the main portion of factor VII occurs in an inactivated form (factor VII 
zymogen) and a small portion in the activated form. There are several methods for 
measurement of factor VII (Figure 2.1). 
A recent technique is derived from the one stage-clotting assay, using a mutant thrombo-
plastin, which does not activate factor VII during the measurement. With this technique 
the activated part of factor VII (FVIIa) can be measured directly60. FVILC (measured by 
the one-stage-clotting assay) reflects the activated part of factor VII in the blood sample 
and some factor VII zymogen which is inadvertently activated by this technique. 
Figure 2.1. Measurement of factor VII 
1% 
99% 
activated factor VII 
unactivated factor VII 
factor VII in vivo \ FVIIa FVHc FVUchr FVUag 
FACTOR VII ASSAYS 
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For this analysis thromboplastin of several origins, i.e. rabbit, bovine and human, can be 
used, resulting in incomparable FVII:C levels61'62. Only bovine thromboplastin is hardly 
capable of activating factor VII zymogen and measurement of FVILC with this 
thromboplastin could be seen as method to evaluate FVIIa63'64. Furthermore, the incubation 
time of the thromboplastin with factor VII and the factor VH-deficient plasma, will 
influence the outcome of the clotting assay4465. Total factor VII can be determined by the 
chromogenic assay in which all factor VII zymogen is activated and the total activity is 
measured. Another method to assess the total amount of factor VII is by immunologic 
assay, which does not discriminate between factor VII zymogen and FVIIa66. Both last 
assays reflect the total amount of factor VII molecules (factor VII mass) present in the 
blood sample and should give similar results61. 
Mechanisms behind the relation between factor VII and dietary fat 
Three different mechanisms are suggested by several authors to explain the relation 
between dietary fat and factor VII. Some of these mechanisms explain only the relation 
with FVIIt, others only with FVILC. 
Binding of factor VII 
Carvalho et al67 suggest that dietary fat has an effect on factor VII through prolonged half-
life time of factor VII in the circulation, caused by binding of factor VII protein with 
triglyceride rich lipoproteins (TRLP). In an in vitro study binding of very low density 
lipoproteins (VLDL), low density proteins (LDL), high density proteins (HDL) and 
chylomicrons with FVII was observed67. The bond of FVII with LDL was less strong than 
with the other lipoproteins. No evidence has been obtained for binding in vivo, because no 
FVIIt was found in the isolated lipoproteins. However, the labile adsorption of FVIIt may 
have been abolished by the ultracentrifugal procedure, which was used for isolation of the 
lipoproteins. These data support only part of the theory; a binding between FVIIt and 
TRLP in vitro was found, whether this binding indeed prolongs the half-life time of factor 
VII protein has not been established. 
Induced synthesis of vitamin K-dependent clotting factors 
Another possibility for increased factor VII zymogen might be enhanced synthesis in the 
liver. It is suggested that activation of the extrinsic pathway by increased generation of 
prothrombin fragment 1+2 may lead to stimulation of the hepatic production of factor VII 
and other vitamin K dependent proteins27,68. This was shown in rabbits where intravenous 
injection of the fragment 1 region of prothrombin is associated with a transient increase in 
20 
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the plasma concentration of factor II and factor X69. The positive association of vitamin K-
dependent clotting factors with total cholesterol, LDL-cholesterol and triglycerides also 
supports this hypothesis22. In most studies on the effect of dietary fat on factor VII, 
however, other vitamin K-dependent clotting factors have not been measured, with the 
exception of factor X. The whole set of vitamin K-dependent clotting factors should be 
considered when this mechanism is further investigated. 
Activation of factor VII by negatively charged surfaces 
A third option for the mechanism behind the association of dietary fat with FVILC is 
activation of factor XII, and thereby factor VII, by the negatively charged surface of the 
TRLP70. Several in vitro experiments showed that when stearic acid or vesicles, with a 
negative charge and size similar to TRLP, were added to plasma, FVILC increased in a 
dose-dependent manner. Oleic acid and other unsaturated fatty acids had no effect on 
FVILC71,72. Lipoprotein lipase (LPL) seems to be important in this reaction; when plasma 
of hypertriglyceridaemic patients with LPL deficiency was treated with LPL factor XII 
was promptly activated73. Thus, long-chain saturated fatty acids in the interface of lipopro-
tein remnants, produced by the interaction of TRLP with lipoprotein lipase (LPL), appear 
to provide the negatively charged surface that activates factor VII. 
Chronic effects of dietary fat 
Several experimental studies have recently been carried out to examine the effect of fat 
rich diets on fasting FVILC or FVIIt (Table 2.1). Effects of high-fat and low-fat diets 
were compared and effects of diets rich in saturated or unsaturated fat on FVILC or FVIIt 
were examined. Some studies focused on the effect of fish or fish-oil on FVILC. 
Effects of high-fat vs low-fat diets 
Three randomized cross-over studies36,74,75, one controlled76 and one uncontrolled25 
intervention study in healthy adults compared high-fat with low-fat diets with respect to 
FVILC. In all studies, except one36, the diets were isocaloric and the ratio of 
polyunsaturated and saturated fat was higher in the low-fat diets compared to the high-fat 
diets. The differences in fat intake between the two experimental diets ranged in these 
studies from 7 en% to 50 en%. In two studies the change in fat was accompanied with a 
change in fibre intake, which must be taken in mind when comparing the results, since 
fibre intake might lower FVILC7576. FVILC was significantly lower after the low-fat diet 
compared to the high-fat diet in four studies25,36,75'76. Marckmann et al74 could not find an 
effect of either diet on FVILC, but the difference between the high and 
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low-fat diet was merely 8.3 en%. In the study of Brace et al25 the effect was even smaller, 
but the low-fat diet lasted for 20 weeks compared to 2 weeks in the study of Marckmann 
et al74. However, most of the reduction in FVII:C in the study of Brace et al25 occurred 
during the first four weeks of the low-fat period. The contradicting results might be due to 
a difference in ratio of the fatty acids of the diets used in both studies, or by the lack of a 
control group in the study of Brace et al25. 
One cross-sectional study in 198 rural Finnish men aged 70 to 89 showed a positive 
correlation of total fat intake and fasting FVII:C24. Whether this association indeed reflects 
chronic effects of total fat intake on FVILC is, however, not clear. 
There was no difference in FVIIt after a low or a high-fat diet2575, but in one study, where 
the participants were put on a two week low-fat diet after their habitual high- fat diet, 
FVIIt dropped significantly with 10-15% of initial values20. Furthermore Miller et al77 
reported a positive association between dietary fat intake and FVIIt. 
Effects of high-saturated vs high-unsaturated fat diets 
Diets with the same total fat content, but with a different fatty acid composition were 
tested in six randomized cross-over studies10'26'27'54,78'79 and one study in which subjects 
received dietary counselling80. All included healthy subjects between 21 and 66 years and 
duration of the diets varied from three weeks to six months. No difference was found in 
FVILC or FVIIt between diets containing mainly saturated fatty acids (safa), monounsa-
turated fatty acids (mufa) or polyunsaturated fatty acids (pufa)20,54'78'80. Three studies 
examined the effect of diets differing only in saturated fatty acid composition. FVII:^ was 
significantly lower after a high stearic acid diet compared to a high palmitic or 
myristic/lauric acid diet26'27. The decrease in FVILC after a high stearic acid diet was 
accompanied by a decrease in FVIIt2627. Slightly higher FVILC levels were found after a 
high myristic acid diet compared to a high palmitic acid diet79. Probably, the stearic acid 
content in saturated fat diets used in the studies mentioned above was not high enough to 
result in lower FVILC levels after high safa diets. Also, some substances in the sheabutter 
(containing 7% unsaponifiable material), which was the origin of the stearic acid, might 
have influenced the factor VII metabolism. 
One cross-sectional study showed a positive association of FVILC with saturated and 
monounsaturated fat. No association was found between FVILC and polyunsaturated fat24. 
This might be due to the low intake of polyunsaturated fat (mean=14.9 g/day, SD=8.6) in 
this study population. 
Many studies8'"90 payed special attention to the effect of fish or fish-oil supplementation on 
fasting FVILC levels, but only in two of them81'90 an effect was observed. FVILC 
increased significantly after supplementation with 10 g fish oil daily81'90. However, in one 
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of these studies81 diabetes patients were included in stead of healthy subjects, and in both 
studies the fish-oil supplementation was relatively high81,90. 
Concluding remarks 
Fasting FVILC is likely to decrease after a low-fat diet compared to consumption of a 
high-fat diet, while the results on fasting FVIIt are not corresponding. There is no 
difference in effect on FVILC or FVIIt after intake of mainly safa, mufa, pufa or fish 
(oil). Apparently the amount of fat is a more important determinant of FVILC than the fat 
composition. Only stearic acid appears to behave differently with a remarkable lowering 
effect on FVILC. 
Acute effects of dietary fat 
In several studies the effect of dietary fat on postprandial factor VII levels was examined 
(Table 2.2). Low-fat meals were compared to high-fat meals and FVILC or FVIIt was 
measured. Others compared the effects of saturated and unsaturated fat meals on FVILC 
and FVIIt. In patients with hyperlipidaemia or cardiovascular disease the effect of one 
fatty meal was investigated. 
The effect of low-fat vs high-fat 
The effect of a high-fat meal and a low-fat meal on postprandial factor VII levels has been 
investigated in a number of studies of different designs. 
A randomized cross-over study of Marckmann et al29 the effects of a high-fat (50 % of 
energy = en%) meal on FVILC and FVIIt in six healthy males (21-30 years) was investi-
gated. The meal resulted in a high postprandial FVILC peak. FVIIt varied insignificantly 
during the 24-h period. A second study with similar design showed also an elevation of 
FVILC after a high-fat meal, but postprandial FVIIt was lower compared to fasting 
levels30. Silveira et al31 and Moor et al91 conducted a fat-tolerance test among 33 patients 
who survived a first myocardial infarction and 10 healthy control subjects (mean age 48.8 
± 3.2 years). Levels of FVILC increased in both groups, but more pronounced in control 
subjects. In contrast, FVIIt tended to be lower in the three-hour sample in patients and 
controls and gradually returned to baseline towards the end of the 12-hour period. 
In two randomized cross-over studies FVILC increased after two high-fat meals32,92 com-
pared to a fat-free meal. The difference between one of the high-fat meals and the fat-free 
meal after eight hours was 10.4%32. This difference is large enough to have biological 
significance, since the difference in FVILC between people with no ischaemic heart 
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disease and those with (fatal) ischaemic heart disease is 4-10%'2,93. FVIIt decreased after 
all meals in one study32, while it increased only after a high saturated fat meal and did not 
change after the fat free meal in another study92. 
The effect of a low-fat meal (20 en%) was evaluated in two studies with similar 
design29,30. In one study FVII:C increased after the low-fat meal, but not as much as after a 
high-fat meal. Factor Vllt did not change. The other study showed a decrease in FVII:C 
and FVIIt after the low-fat meal. 
The effect of high saturated vs high unsaturated fat 
The response of FVII:C and FVIIt on a meal with mainly saturated or unsaturated fat was 
compared in different cross-over studies among small numbers of healthy middle-aged 
subjects2832'92. Two studies included a low-fat control meal32,92. In the study of Salomaa et 
al32 the post-prandial effect of a fat meal was tested, while the other studies evaluated the 
post-prandial effects after a one or four-week diet28'92. There was no difference in the post-
prandial change of FVILC or FVIIt between the high saturated and high unsaturated meal 
in two studies2832. However, in one study FVILC was highest on the saturated fat meal, 
intermediate on the unsaturated fat meal and lowest on the control meal. Factor Vllt levels 
did not differ significantly between the unsaturated fat and control meal, but were 
significantly increased on the saturated fat meal92. 
Concluding remarks 
Some of the studies mentioned above comprised a diet-period of several days where blood 
samples were taken on the last day of each diet-period. In others the effect was just 
evaluated after one test-meal. Also, the composition of the meals, the number of partici-
pants and the time of blood sampling differed between the studies. Nevertheless, results 
were in general quite similar. Furthermore, in studies on acute effects as well as in studies 
on chronic effects of dietary fat on factor VII more or less the same conclusions can be 
drawn; an increase after a high-fat meal/diet and probably no different effects of several 
fatty acids. 
There seems to be no difference in postprandial response of FVILC or FVIIt between 
saturated fat consumption and unsaturated fat consumption, but this might be due to low 
numbers. FVIIt does not appear to increase after any type of meal. Probably factor VII 
protein only decreases due to endogenous fluctuations. FVILC always 
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responds with an increase after high-fat meals, but it is not yet clear whether this response 
also occurs after a low-fat meal. 
Blood lipids 
Blood lipids may have an important role in the relation between dietary fat and factor VII. 
Many researchers have investigated this by relating blood lipids to (fasting or postprandial) 
factor VII in blood samples taken at the same time. In these studies triglycerides and 
FVILC or FVIIt were analyzed. Also, total cholesterol, HDL cholesterol or sometimes 
LDL cholesterol were measured. Furthermore, the association of triglycerides and 
cholesterol with factor VII was evaluated in intervention studies on chronic effects of a 
diet on factor VII. Since the design of these intervention studies is described above, we 
will not go into detail on this here. Finally the relation between blood lipids and FVILC 
and FVIIt was investigated in patients with primary hyperlipidaemia. 
Factor VII and triglycerides 
All cross-sectional studies which included measurements of triglycerides showed a positive 
correlation between triglycerides and FVILC243739'9497, or FVIIt16-37-40-429596. Four of the 
studies did not comprise women2438,39-95 and one study, in which FVILC and FVIIt 
measurements were done among men and women, showed only a correlation between 
triglycerides and FVIIt in men4'. The participants in this study were relatively young 
(mean age men 23 and women 24 years) compared to other studies which were carried out 
among middle-aged or elderly people, so the studies might not be completely comparable. 
In most of the studies factor VII was measured after an overnight fast, the authors of two 
articles, however, did not mention the state of the participants when blood samples were 
drawn37-42. 
In eight intervention studies triglycerides and FVILC were measured. None of these 
studies showed a positive association between triglycerides and FVILC20-25-27-74"76-79. In five 
studies FVILC decreased after a low-fat diet, while triglycerides did not change or even 
increased2574"76. 
Factor VII and cholesterol 
Findings on the relation of serum cholesterol concentration with factor VII in healthy 
subjects are much less consistent. Eight out of 13 cross-sectional studies showed a positive 
association between total cholesterol and FVILC243739-41-95-98, or FVIIt37-4'-42-95 which was 
stronger in men than in women3741,98. 
HDL and LDL cholesterol positively correlated with FVILC in one study94 while they 
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were positively associated with FVIIt only in men in another study41. In several studies a 
correlation between those parameters could not be found at all16,37-38,40,41,94,97. Finally, Yang 
et al" reported a positive correlation between total cholesterol/HDL cholesterol ratio and 
FVIIt in 48 healthy men. 
In two intervention studies a positive association between total cholesterol and FVILC was 
found20'36. In six other studies the change in total cholesterol was coherent with the change 
in factor VII, but nothing was mentioned on the association between these variables25,27,74" 
Factor VII in hyperlipidaemic patients 
Patients with primary hyperlipidaemia, type Ha, lib or IV of the Fredrickson classifica-
tion'00 participated in several studies in which fasting factor VII and blood lipids were 
measured55'01'02. FVILC and FVIIt were higher in middle-aged patients with type Ha, lib 
or IV hyperlipidaemia compared to healthy controls of the same age55,10'102. For FVIIt this 
difference was not significant55,10'. Another study among elderly patients, showed elevated 
FVILC and FVIIt levels in patients with type Ha and lib but not in type IV 
hyperlipidaemia compared to controls103. Nordoy et al104 found opposite results in a study 
where patients with type IV but not type Ha and lib had higher FVIIt levels. One 
explanation for these contradictory results might be that in the latter study a different 
method was used to measure factor VII (factor VII normotest, which measures FVII-
phospholipid complex) and that blood samples were not taken after an overnight fast104. 
Other differences between studies might further have complicated the results; some 
patients received treatment, but according to the authors this treatment did not interfere 
with coagulation parameters. Some controls used lipid-lowering diets, but this does not 
explain the different results found for type II and IV hyperlipidaemic patients. In view of 
the evident relation between triglycerides and factor VII and the weak association between 
cholesterol and factor VII, it could have been expected that factor VII was higher in 
patients with increased levels of triglycerides, i.e. type lib and IV hyperlipidaemia. Still, 
this was not confirmed in the studies mentioned above. 
Concluding remarks 
There is convincing data from cross-sectional studies which show a relation between 
triglycerides and FVILC or FVIIt. This is not confirmed by results from intervention 
studies. The cross-sectional association might only reflect the association of FVILC and 
triglyceride after a fat-rich (evening) meal. This indicates that the change in factor VII 
after a long-term diet is independent of triglycerides, while post-prandial change in factor 
VII does depend on triglycerides. 
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The association between different subfractions of cholesterol and FVII:C or FVIIt is not 
quite clear. This may be due to different types of participants in studies performed thus 
far; diabetes patients, hypertensive patients, or healthy participants were included. Also, 
differences in age distribution of the participants may have accounted for the discrepancy 
in results. More likely however, the relation of cholesterol with FVILC and FVIIt is due to 
the associations between FVILC and large lipoprotein particles, chylomicrons, VLDL and 
IDL70. The interrelation between triglycerides and cholesterol might explain the association 
of factor VII with cholesterol. Unfortunately in the reported studies, the associations 
between cholesterol and factor VII were not adjusted for triglyceride levels. 
Gene-environment interaction: factor VII polymorphism and triglycerides 
FVII polymorphism 
Recently a polymorphism for the factor VII gene was identified, which is strongly 
associated with plasma FVILC levels23. The base change causing the polymorphism is a G 
to A substitution in the second position of the codon for amino acid 353, leading to 
replacement of arginine (R) by glutamine (Q) in the protein product of the allele 
(R/Q353). The Q allele is associated with relatively low FVILC levels while, the R allele 
is associated with relatively high FVILC levels23,57'05'07. In Caucasians Q allele frequencies 
of 0.06, 0.09, 0.10 and 0.13 have been reported23'57106107. In Dravidian Indians, Gujaratis 
and Afro-Caribbeans the frequency of this allele was 0.29, 0.25 and 0.08 respectively57105. 
Interaction with dietary fat and triglycerides 
Lane et al57 reported that the association between triglycerides and FVILC among 
Caucasians, Afro-Caribbeans and Gujarati Indians depended on the R/Q353 genotype. In 
the Gujaratis no correlation between triglycerides and FVILC was found among those with 
the Q allele, while a correlation was present in persons with the RR genotype. The same 
results were found in a study by Humphries et al58, who examined FVILC and FVIIt in 
364 Caucasian men. However, in a study of Saha et al105, where fasting FVILC levels were 
compared with triglyceride levels in Dravidian Indians, the opposite was true; the relation 
between triglycerides and FVILC was stronger in persons with the RQ or QQ genotype 
than in persons with the RR genotype105. In a study of Silveira et al106 31 male post-infarct 
patients underwent a fat-tolerance test and FVIIa, FVIIt and triglycerides were measured. 
The association between postprandial triglycerides response and fasting FVIIt was not 
significant in participants with the RQ genotype, while it was significant in those with the 
RR genotype. In both the RQ group and the RR group a significant association between 
triglyceride and FVIIa response on the test meal was found. It is likely that the 
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polymorphism considerably modifies the association between fasting factor VII levels and 
triglycerides. It is, however, from these studies not clear whether this association is 
stronger in persons who carry the Q allele or in those with the RR genotype. This might 
be due to the fact that the R/Q353 polymorphism itself is not a direct determinant of the 
factor VII response, but may be in strong allelic association with some causative 
polymorphic sequence somewhere else on the factor VII gene. 
There are so far little data which suggest that the genotype influences the postprandial 
response of FVIIa on a fat load. In the study of Silveira et al106 FVIIa increased in both 
genotype groups in response to fat intake and the differences between RR and RQ 
individuals in the fasting state were maintained in the postprandial state106. The absolute 
postprandial rise in FVIIa was higher in the RR group than in the RQ group. However, so 
far this study is the only postprandial study in which genotype has been taken into 
account. Considering this, and the contradicting results of studies on the effect of genotype 
on the association between triglycerides and factor VII, more research is needed to 
document the interrelations between factor VII, triglycerides, dietary fat, R/Q353 and 
other polymorphisms. 
Discussion and conclusion 
It is not surprising that results of studies investigating factor VII are not always consistent. 
Several methods are presently used to measure factor VII, not all of which are compara-
ble. The method most widely used, i.e. one-stage clotting assay, is the one with most 
uncertainty on what is actually measured. As the activated form of factor VII has a 
priming function in triggering the clotting cascade, measurement of FVIIa seems the most 
relevant way to study factor VII. So far this method has rarely been used in studies on 
factor VII and dietary fat. 
Another complication is the difference in timing of blood sampling; results of studies on 
fasting and postprandial levels are in fact incomparable. More importantly, different 
mechanisms might account for effects of dietary fat and blood lipids on fasting and 
postprandial factor VII. For example, after a long-term high-fat diet, fasting levels might 
be higher, but also the response of factor VII on a fat load might be more pronounced 
than after a long-term low-fat diet. It is known, for example, that the response of lipopro-
teins on a fat load is not only dependent on the type of fat given but also on the type of 
fat which is habitually consumed108. Furthermore, the R/Q353 polymorphism probably 
modifies this reaction. 
Factor VII is a risk indicator for cardiovascular disease, the association being stronger 
between factor VII and fatal events than non-fatal events. Trace amounts of FVIIa 
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represent the very first active protease in the extrinsic pathway of coagulation and elevated 
plasma levels of FVIIa may give rise to an extensive initiation of the clotting cascade after 
rupture of atherosclerotic plaques. Factor Vila may in particular be important in the 
outcome of a thrombotic event, perhaps through the eventual size of the occlusive 
thrombus. 
For the purpose of prevention of cardiovascular disease through a change in dietary habits, 
it is necessary to know if and how the level of FVIIa can be influenced. In this context, it 
is good to reflect on the mechanism that might explain the relation between dietary fat and 
factor VII. Data of studies on this topic are insufficient to throw light on which of the 
mechanisms that are proposed is really relevant. There are still many questions to be 
solved. For example, why do we not find an increase in FVII:C after saturated fat intake 
and a decrease after consumption of fish(oil), since the half life time of chylomicron 
remnants is longer after a saturated fat meal and shorter after intake of fish oil108109. 
Furthermore, in the fasting state almost no large lipoprotein particles are present in the 
circulation; no activation by lipoproteins can occur, so how does that explain the higher 
fasting FVII:C levels found after a high-fat diet in some studies? Answers to these 
questions could support or refine the presently proposed mechanisms or reveal a new 
theory. 
Many studies have been performed suggesting that factor VII, dietary fat and blood lipids 
are somehow related, independent from other factors. It seems quite clear that the amount 
of fat intake is important; high-fat meals increase factor VII. Whether fat composition is 
of any importance remains to be clarified. Intervention and biochemical studies are needed 
to investigate this and to find the explaining mechanism behind this relation. For further 
research it is advisable that total factor VII and FVIIa is measured with one standard tech-
nique for each method, and that blood is collected at fasting and postprandial conditions. 
Also, the polymorphisms of the gene coding for factor VII should be taken into account 
while studying the relation between factor VII, dietary fat and blood lipids. 
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The association of dietary fat and fibre with coagulation factor VII 
in the elderly: The Rotterdam Study 
Abstract 
Considerable evidence suggests that a high concentration of coagulation factor VII is a 
risk indicator for ischaemic heart disease. Factor VII is known to be influenced by dietary 
fat and probably by dietary fibre in young and middle-aged people. There are no data 
available in elderly people and the effects of different types of fat are unclear. This study 
examines the relation of factor VII coagulant activity (FVII:C) with dietary fat and fibre in 
The Rotterdam Study. The Rotterdam Study is a population-based study among 7983 men 
and women, aged 55 years and over. FVILC was measured in 3007 subjects (1730 women 
and 1277 men, mean age 67.3 ± 7.8 and 66.3 ± 7.0 years respectively). Measurements 
included cardiovascular risk factors and habitual diet was assessed by a semiquantitative 
food-frequency questionnaire. Associations that were statistically significant or nearly 
significant differed for some nutrients between men and women. Total fat intake showed a 
direct association with FVILC only in women (6=0.1 %/g, 95%CI:0.01,0.20). Saturated fat 
intake was associated with FVILC in women (6=0.18 %/g, 95%CI: -0.001,0.36) and in 
men (6=0.11 %/g, 95%CI:-0.06,0.27). Monounsaturated fat was positively related to 
FVILC in women (6=0.17 %/g, 95%CI:-0.05,0.39 and polyunsaturated fat was inversely 
associated with FVILC in men (6=-0.15 %/g, 95%CL-0.33,0.03). Fibre intake was 
inversely associated with FVILC in both men (6=-0.31 %/g, 95%CL-0.57,-0.06) and 
women (6=-0.36 %/g, 95%CL-0.63,-0.09). No associations were found for energy intake. 
In elderly people FVILC is associated with fat and fibre intake. This suggests that FVILC 
is influenced by nutritional factors, even at old age. 
L.I. Mennen. J.C.M. Witteman, J.H. den Breeijen, E.G. Schouten, P.T.V.M. de Jong, A. 
Hofman, D.E. Grobbee 
Am J Clin Nutr 1997;65:732-736 
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Introduction 
Factor VII is one of the coagulation factors of the extrinsic pathway of the coagulation 
cascade. This pathway is activated during vascular injury, which results in the rapid 
formation of a blood clot. A high concentration of factor VII contributes to a high 
thrombotic tendency. In the presence of atherosclerosis, this tendency may be a trigger for 
a cardiovascular event. Atherosclerosis is common in elderly people, reflecting a develop-
ment over many years. The effects of thrombosis, however, are acute and subject to 
change even at older ages. Increased thrombotic tendency in elderly people constitutes an 
elevated risk for cardiovascular disease and considerable evidence indeed suggests that 
factor VII coagulant activity (FVILC) is a major contributor1,2. In the Northwick Park 
Heart Study (n=1511) factor VII was found to be a risk indicator for ischaemic heart 
disease' and in the PROCAM study (n=10581) this seemed to be the case when only fatal 
events were taken into account2. 
Two nutritional factors, dietary fat and fibre, are considered major environmental 
determinants of FVII:C. From several intervention studies among young adults it is known 
that FVILC depends on dietary fat intake'030"3236,92. A high-fat diet results in high FVII:C 
levels and after a fatty meal post-prandial FVILC rises concomitantly with the rise in 
triglycerides30"32,92. These changes in FVILC are believed to be independent of the type of 
fat consumed20,36. The results from three observational studies among middle-aged men 
however, are inconsistent34,36"0. Connely et al"° and Miller et al36 observed an association 
between FVILC and dietary fat whereas Rankinen et al34 did not. 
Three cross-over trials in young and middle-aged subjects showed a decrease in FVILC 
after a high-fibre diet35,75,76. An association between dietary fibre and FVILC was also 
observed in one cross-sectional study34. No other nutrients have consistently been found to 
be associated with FVILC30,36. 
To our knowledge, there are no published data on FVILC and dietary factors in elderly 
people. It is important to know whether the association of FVILC with dietary factors also 
exists at an age when most cardiovascular events occur. Because the level of FVILC 
directly influences the thrombotic tendency, in the presence of atherosclerosis it may 
determine whether a cardiovascular event is triggered. We studied the relation between 
FVILC and dietary fat and fibre in the Rotterdam Study. 
34 
Dietary fat and fiber 
Subjects and methods 
Population 
The Rotterdam Study is a single-center population-based prospective cohort study of 7983 
persons. All inhabitants of 55 years and over from a suburb of Rotterdam were asked to 
participate in the study, which resulted in a response rate of 78%. In short, the objective 
of the study is to clarify determinants of occurrence of chronic disabling cardiovascular, 
neurogeriatric, locomotor and ophthalmologic diseases. The rationale and design of the 
Rotterdam Study have been published elsewhere"1. 
Dietary data were available for 5435 persons and study subjects were excluded for the 
following reasons: myocardial infarction in the year before the investigation (n=574), 
diabetes mellitus (n=779), use of anticoagulants (n=1349), stasis during venepuncture 
(n=1513) and no blood sample available (n=933). Because some subjects were excluded 
for multiple reasons, a total of 4976 were not eligible for this study. The present analysis 
is thus based on cross-sectionally obtained data for 3007 subjects. 
Examination procedures 
The participants came to the research center at varying times during the day. At the 
research center a brief clinical examination was performed and height and weight were 
measured. Body mass index was determined by dividing the weight by the square of 
height (kg/m2). Blood pressure was measured, with the subject in a sitting position, at the 
right arm by using a random zero sphygmomanometer. The participants were not asked to 
refrain from smoking or physical exercise and non-fasting blood samples were taken using 
a 21 gauge butterfly needle after no or minimal stasis. 
Dietary assessment 
The habitual diet was assessed by a semiquantitative food-frequency questionnaire. The 
questionnaire was a modification of a validated self-administered mailed semiquantitative 
food-frequency questionnaire that was used previously in a large-scale prospective cohort 
study, involving a younger population. Measures of the validity and repeatability of the 
original questionnaire for several nutrients have been reported"2"3. The questionnaire was 
adapted to allow an easy and time-efficient dietary assessment in an older population. 
Modification consisted mainly of inclusion of additional items (icecream, cornflakes and 
linseed); collection of more detailed information on vegetable, fruit, and meat 
consumption; and a different mode of administration, which was undertaken in two 
consecutive phases. The modified questionnaire contains 170 food items in 13 food groups 
and general questions about dietary habits. Its aim is to assess habitual food intake during 
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the past year. 
In the first phase a self-administered questionnaire was handed out and explained to each 
participant by trained research assistants during a home visit. Participants had to mark the 
foods that they consumed at least once a month. Also, the amounts of several foods they 
used were weighed and the content of cups and bowls was measured. In the second phase 
a dietary interview was conducted by trained dietitians on the basis of the already com-
pleted dietary questionnaire. During the dietary interview the dieticians concentrated on 
obtaining accurate information on amount and frequency of food items noted by partici-
pants as consumed at least once a month. General questions to check the consistency of 
the completed dietary questionnaire were asked. The modified questionnaire was validated 
by comparison with multiple food records. The correlation coefficients were corrected for 
within-person variation in food records and adjusted for age, sex and energy intake. For 
the different types of fat and fibre they varied between 0.50 to 0.65 (Klipstein et al, 
unpublished observations, 1994). 
All data were entered into a self-made interactive computer program, which included 
automatic checks for inconsistencies in the answers of the participants. A computer 
application was developed to calculate the frequency and amounts of foods consumed. 
Questionnaires were checked for completeness by an interactive dataentry program and 
automatically coded for later conversion into nutrients. The program checked further for 
consistency, range and other response errors. The conversion from foods to energy and 
nutrient intake was done with a computerized version of the Dutch Food Composition 
Table"4 and percentages of total energy (en%) delivered by macronutrients were 
calculated. 
Laboratory measurements 
Samples were collected into siliconized vacutainer tubes containing 0.129 mol/L sodium 
citrate (Becton Dickinson, Meylan, France). Samples were centrifuged for 10 minutes at 
1600 x g and 4°C. Citrated plasma was snap frozen and stored at -80°C until analyzed. 
FVILC was measured with a one-stage clotting assay by using human thromboplastin 
(Tromborel S, Behringwerke, Germany) and factor VH-deficient plasma (Ortho Diagnostic 
System, Beerse, Belgium). This assay measures the ability of the sample to correct the 
clotting time of human factor VH-deficient plasma. The plasma levels were then expressed 
as percentage activity by relating the clotting time to a calibration curve constructed of a 
standardized control plasma. As a control, the pooled plasma of 50 healthy middle-aged 
people was used and three control samples were run with each batch of study samples. 
The coefficient of variation is 7.3% for this method. Serum total cholesterol was 
determined using an automated enzymatic procedure"5. HDL-cholesterol concentration was 
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measured similarly, after precipitation. 
Data analysis 
The association of FVILC with dietary factors was examined by multiple linear regression 
analysis, using the BMDP-statistical package"6. In the analysis, both total weight and en% 
of macronutrients were used. Adjustments were made for age and when nutrients in grams 
were used in the analysis, adjustment for energy intake was made by including total 
kilojoules as an independent variable in the regression model. In some models we included 
additional nutrients when appropriate. 
Table 3.1. General characteristics of the study population (means ± SD) 
Women 
(n=1730) 
Men 
(n=1277) 
Age (years) 
Total cholesterol (mmol/L) 
HDL-cholesterol (mmol/L) 
Systolic blood pressure (mmHg) 
Diastolic blood pressure (mmhg) 
Body mass index (kg/m2) 
Factor VII:C (% of standard) 
Smoking (%): current 
former 
never 
67.3 ± 7.8 
6.9 ± 1.2 
1.5 ±0.4 
137.6 ±21.6 
72.9 ± 10.8 
26.6 ± 4.0 
120.4 ± 24.3 
19.1 
28.8 
52.1 
66.3 ± 7.0 
6.4 ± 1.2 
1.2 ± 0.3 
137.5 ±21.1 
75.3 ± 11.3 
25.8 ± 2.8 
108.0 ± 22.5 
24.6 
58.6 
16.8 
Results 
General characteristics of the study population are presented in Table 3.1. Mean age was 
66.3 years in men and 67.3 years in women. Mean FVILC was 108.0% in men and 
120.4% in women. Energy and nutrient intakes from the subjects' habitual diet are shown 
in Table 3.2. Mean energy intake was 9546 kJ in men and 7515 Kj in women. 
The coefficients and 95% confidence intervals of regression analysis with FVILC as 
dependent variable and nutrient intake as independent variable are shown in Table 3.3. 
Total fat intake showed a direct association with FVILC only in women. Saturated fat 
intake was associated with FVILC in women; in men the association was smaller. 
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Monounsaturated fat was positively related to FVII:C in women and polyunsaturated fat 
was inversely associated with FVII:C in men. In general, the results were the same when 
calculated for the percentage of energy delivered by the nutrient as for the absolute intake. 
Table 3.2. Calculated daily energy and nutrient intake (means ± SD) 
Women Men 
(n=1730) (n=1277) 
Energy (kJ) 7515 ± 1687.0 9546 ±2119.6 
g en% g en% 
Protein 75.9 ± 16.6 17.2 ± 3.1 89.6 ± 21.2 15.9 ± 2.7 
Carbohydrates 197.2 + 53.5 43.9 ± 6.7 241.7 ± 65.1 42.5 ± 7.0 
Total fat 73.1 ±23.0 36.2 ± 6.2 93.6 + 29.1 37.0 ± 6.0 
Saturated fat 29.2 ± 10.2 14.5 ±3.3 36.5 ± 12.4 14.3 + 3.0 
Monounsaturated fat 24.8 ± 8.5 12.3 ± 2.7 32.2 ±11.3 12.6 ± 2.7 
polyunsaturated fat 13.5 ± 6.8 6.7 ± 2.8 18.0 ± 8.3 7.1 ± 2.7 
Cholesterol1 216.8 + 70.3 263.5 + 90.5 
Fibre 16.1 ±4.8 18.2 ± 5.4 
the percentage energy delivered by the nutrient 
# . in mg 
Furthermore, total cholesterol intake was associated with FVII:C in men and women, but 
when saturated fat was included in the regression model the regression coefficients of 
cholesterol were smaller. Fibre intake was inversely associated with FVII:C in both men 
and women. When this association was adjusted for total, saturated, or polyunsaturated fat 
the results did not change. No associations were found with energy intake. 
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Table 3.3. Regression coefficients and 95% confidence (95% CI) intervals of several 
dietary components and factor VII:C* 
Women 
(n=1730) 
Men 
(n=1277) 
Energy (1000 Kj) 
Total fat 
Saturated fat 
Monounsaturated fat 
Polyunsaturated fat 
Cholesterol 
Fibre 
* All models adjusted for age. When intake in grams was used in the model, the model was also adjusted 
for total energy intake. The regression coefficients denote the change in factor VII:C as a percentages per 
unit change in nutrient intake. 
Discussion 
We investigated associations of several nutrients with FVII:C among 3007 elderly people. 
Associations that were statistically significant or nearly significant differed for some 
nutrients between men and women. Plasma FVILC levels were associated with cholesterol 
and with fibre intake in both women and men. Also, an association was observed between 
FVILC and saturated fat intake, which was stronger in women than in men. Furthermore 
FVILC was related to total and monounsaturated fat in women and to polyunsaturated fat 
in men. Energy intake was not associated with FVILC. 
g 
en% 
g 
en% 
g 
en% 
g 
en% 
mg 
g 
6 
0.3 
0.10 
0.23 
0.18 
0.40 
0.17 
0.40 
0.04 
0.14 
0.02 
-0.36 
95% CI 
-0.4,1.0 
0.005,0.20 
0.04,0.41 
0.001,0.36 
0.05,0.75 
-0.05,0.39 
-0.03,0.83 
-0.16,0.24 
-0.27,0.55 
-0.0003,0.04 
-0.63,-0.09 
B 
-0.3 
0.11 
0.25 
0.11 
0.25 
0.03 
0.06 
-0.15 
-0.36 
0.02 
-0.31 
95% CI 
-0.9,0.3 
-0.06,0.27 
-0.16,0.66 
-0.06,0.27 
-0.16,0.66 
-0.15,0.20 
-0.39,0.51 
-0.33,0.03 
-0.81,0.09 
0.0002,0.04 
-0.57,-0.06 
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Factor VII activation was determined by a one-stage clotting assay, a method that is 
commonly used in other studies1,2. Although determination of factor VII with an improved 
method (factor Vila)60 may have been preferable, this measurement was not in use at the 
start of our study in 1991. 
Furthermore, in this study blood samples were collected from subjects in a nonfasting 
state. However, when we adjusted the associations for the time since the last meal, the 
results did not change. 
There have been several intervention studies that compared the effect of saturated and 
unsaturated fat on FVILC20,28,32,54. In a cross-over trial among 21 male and 17 female 
subjects a diet rich in mono- or polyunsaturated fat was consumed for 23 days, and no 
change in FVII:C was found on either diet54. Another cross-over trial among 11 young 
adults, in which two low-fat diets were given, showed a similar decrease in FVILC after a 
diet with mainly saturated fat compared with a diet with mainly unsaturated fat20. Also, 
there was no difference in post-prandial levels of FVILC after a meal with high saturated 
fat or a meal with high polyunsaturated28'32. The results of these studies suggest that 
FVII:C decreases with a low-fat diet, irrespective of the type of fat. 
In two cross-sectional studies among middle-aged men, a positive association of FVILC 
with dietary fat was also observed30,36,110, but nothing was reported for associations of 
FVILC with different types of fat. 
The results of the trials mentioned above showed positive associations of FVILC with all 
fat types. This is not in line with the results of our study. In those trials however, 
saturated and unsaturated fats were fully exchanged in the different diets to get a high 
contrast between the fat types. This results in an unnaturally high intake of unsaturated fat; 
the intake of unsaturated fat in an ordinary Western diet is much lower2054. Because data 
on habitual diet were used in our study, the intake of unsaturated fat may have been too 
low to uncover a positive association with FVILC. 
The results of our study showed some differences between men and women, but this was 
mainly restricted to mono- and polyunsaturated fat. The lack of association between 
FVILC and total fat in men may be a consequence of the inverse association of 
polyunsaturated fat with FVILC in men, whereas in women monounsaturated fat was 
positively associated with FVILC. We have no other explanations for the differences in 
men and women. 
In agreement with three intervention studies and one cross-sectional study in middle-aged 
subjects34,35,75,76, our cross-sectional study showed an inverse association of FVILC with 
fibre intake in elderly people; an increase of fibre intake of 10 g would result in a 
decrease of FVILC of 3.6% in women and 3.1% in men. Such an increase would raise the 
mean fibre intake towards that recommended by the Dutch Nutrition Council"7. 
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The study conducted here was a cross-sectional study. The results show an association 
between FVILC and dietary factors, but no definite conclusions can be made on a causal 
relation. Two mechanisms have been proposed to explain a causal relation between FVILC 
and dietary fat56,71. One mechanism is based on decreased catabolism of factor VII through 
binding of factor VII protein to triglyceride rich lipoproteins56. The second is based on 
activation of factor VII by negatively charged surfaces which occurs during lipolysis of 
these lipoproteins71. 
The mechanism to explain an association of FVII:C with fibre is unknown so far. A high-
fibre intake may be a marker of a healthy diet or even of a healthy lifestyle. Another 
option is the lowering effect of fibre on blood cholesterol"8, which in turn might have an 
effect on factor VII41. Intervention studies that confirm the specific effect of fibre intake 
on factor VII are needed to disentangle direct and indirect effects. 
A high factor VII concentration increases the thrombotic tendency, which may be a trigger 
for cardiovascular events. If factor VII can be lowered, a cardiovascular event might be 
postponed or even prevented. Because factor VII influences the thrombotic tendency 
directly, even at older ages, lowering of FVILC may be of public health importance. The 
results from this study suggest that FVILC may be affected by a low-fat or a high-fibre 
diet, or both at old age. Intervention studies are needed to further support the preventive 
potential of changes in diet through this mechanism. 
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Dietary effects on coagulation factor VII vary across genotypes of 
the R/Q353 polymorphism 
Abstract 
Coagulation factor VII clotting activity (FVILC) is a risk indicator for cardiovascular 
disease. FVILC is influenced by diet and by the R/Q353 polymorphism. We evaluated the 
association of factor VII with dietary factors taking the R/Q353 polymorphism into 
account. 
In 3005 elderly subjects FVILC was measured and the extreme quintiles of the FVILC 
distribution were selected for measurement of the R/Q353 genotype and total factor VII 
(FVIIt). In these 1158 subjects, habitual diet was assessed with a semiquantitative food-
frequency questionnaire. The frequency of the Q353 allele was 0.24 in the lowest quintile 
and 0.09 in the highest quintile. The quintiles were combined for performance of linear 
regression analyses. 
FVILC was inversely associated with fibre (B=-0.64 %PP/g, CL-1.07,-0.21) and protein 
intake (6=-0.16 %PP/g, CI:-0.31,-0.01) and positively with saturated fat intake (6=0.19 
%PP/g, CL-0.10,0.48). FVIIt was inversely associated with fibre (B=-0.38 %PP/g, CI: 
-0.71,-0.05). No important other associations with diet were observed. 
The inverse association of FVILC with fibre was clearly stronger in subjects with the RR 
genotype (6=-0.76 %PP/g, CL-1.23,-0.29), than in those with the RQ/QQ genotypes (B=-
0.19 %PP/g, CL-0.97,0.59). The same was found for FVIIt. The association of FVILC 
with saturated fat was positive in those homozygous for the R allele and inverse in those 
carrying the Q allele. 
These findings suggest that the strength of the association between coagulation factor VII 
and diet varies across the genotypes of the R/Q353 polymorphism. 
L.I. Mennen, M.P.M. de Maat, E.G. Schouten, C. Kluft, J.C.M. Witteman, A. Hofman, 
D.E. Grobbee 
Submitted for publication 
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Introduction 
Factor VII is a vitamin K-dependent coagulation factor, which together with tissue factor 
is a very potent coagulant5. In the gene coding for factor VII the R/Q353 polymorphism is 
the result of a single base change in the codon for amino acid 353, which leads to the 
replacement of arginine (R) by glutamine (Q)23. The Q353 allele is associated with lower 
levels of factor VII clotting activity (FVILC) and total factor VII23. In the Northwick Park 
Heart Study and the Prospective Cardiovascular Miinster Study FVII:C was shown to be 
positively associated with the incidence of (fatal) ischaemic heart disease''2'6"9. Further-
more, the HVR4 polymorphism, another polymorphism in the factor VII gene of which the 
Al allele is related with lower factor VII levels, was associated with familial acute 
myocardial infarction (Iacoviello et al, unpublished observations, 1997). 
FVILC and total factor VII were found to be positively associated with intake of dietary 
fat in a cross-sectional study77. Results from several experimental studies showed an 
increase of FVILC on a high-fat diet, while it decreased on a low-fat diet2036. The effects 
of a high-fat diet on total factor VII are less clear120. From one intervention study and two 
cross-sectional studies an inverse association of FVII:C with dietary fibre was reported33"35. 
Finally, a change in protein intake was associated with a change in FVILC and total factor 
VII36. 
As the R/Q353 polymorphism substantially influences the level of both FVILC and total 
factor VII'21, the association of factor VII with dietary factors may differ between 
genotype groups. This was evaluated in cross-sectional data from the Rotterdam Study. 
Subjects and methods 
Population 
The Rotterdam Study is a single-centre population-based prospective cohort study of 7983 
persons. All inhabitants of 55 years and over from a suburb of Rotterdam were asked to 
participate in the study, with a response rate of 78%. In short, the objective of the study is 
to clarify determinants of occurrence of chronic disabling cardiovascular, neurogeriatric, 
locomotor and ophthalmologic diseases. The rationale and design of the Rotterdam Study 
have been published elsewhere1". 
Dietary data and blood samples were not available for 2548 and 993 persons respectively. 
The following characteristics may affect the factor VII level and were therefore used as 
exclusion criteria: myocardial infarction in the year before the investigation (n=574 
persons), diabetes mellitus (n=779 persons), use of anticoagulants (n=1349 persons), stasis 
during venepuncture (n=1513 persons). None of the women used hormone replacement 
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therapy. As some subjects were excluded for multiple reasons a total of 4978 was not 
eligible for this study. In blood samples of the 3005 people who were left after exclusions, 
FVILC was measured. Individuals in the two extreme quintiles of the distribution of 
FVILC were selected, expecting an enrichment for the Q353 allele in the lowest quintile. 
The present analysis is thus based on cross-sectionally obtained data for 1158 subjects. 
Examination procedures 
The participants came to the research centre between 08.00 h and 16.30 h. At the research 
centre a brief clinical examination was performed and height and weight were measured. 
Body mass index was calculated by dividing weight by the square of height (kg/m2). Non-
fasting blood samples were taken using a 21 gauge butterfly needle after minimal stasis. 
Time between last meal and blood sampling was recorded. 
Dietary assessment 
The habitual diet was assessed by a semiquantitative food-frequency questionnaire. The 
questionnaire was a modification of a validated self-administered semiquantitative food-
frequency questionnaire that was previously used in a large-scale prospective cohort study, 
involving a younger population. Measures of the validity and repeatability of the original 
questionnaire for several nutrients have been reported112"3. The questionnaire was adapted 
to allow an easy and time efficient dietary assessment in a population of older persons. 
The modified questionnaire contained 170 food items in 13 food groups and general 
questions about dietary habits. The aim was to assess habitual food intake during the past 
year. 
Dietary assessment was undertaken in two consecutive phases. First a self-administered 
questionnaire was handed out and explained to each participant during a home visit by 
trained research assistants. Participants had to mark the foods that they consumed at least 
once a month. Also, the amounts of several foods they used were weighed and the content 
of cups and bowls was measured. Secondly a dietary interview was conducted by trained 
dietitians on the basis of the already completed dietary questionnaire. During the dietary 
interview the dieticians concentrated on obtaining accurate information on amount and 
frequency of food items noted by participants as consumed at least once a month. 
The conversion from foods to energy and nutrient intake was established with a 
computerized version of the Dutch Food Composition Table"4 and percentages of total 
energy (en%) delivered by macronutrients were calculated. 
Laboratory measurements 
Blood was collected in siliconized vacutainer tubes containing 0.129 mol/L sodium citrate 
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(Becton Dickinson). Samples were centrifuged for 10 minutes at 1600 x g and 4°C. 
Citrated plasma was snap frozen and stored at -80°C until laboratory analysis. FVII:C was 
measured with a one-stage-clotting assay using human thromboplastin (Tromborel S, 
Behringwerke, Germany) and factor VH-deficient plasma (Ortho Diagnostic System, 
Beerse, Belgium). The results are expressed as percentages of pooled plasma (%PP). The 
total concentration of factor VII (FVIIt) was estimated by a two-stage amidolytic micro-
titre assay (Chromogenix, Molndal, Sweden)122. For the measurements of FVILC and FVIIt 
different pooled plasma's were used. Serum total cholesterol was determined using an 
automated enzymatic procedure"5. 
DNA was extracted from buffy-coats by a small scale method123. Each polymerase chain 
reaction (PCR) reaction (25 uL) contained 50-100 ng of the DNA extract, 50 ng of each 
appropriate primer, 10 mmol/L Tris/HCL (pH 9.0), 50 mmol/L KCL, 0.01 % gelatin, 0.1 
% Triton X-100, 1 mmol/L MgCl2, 0.2 mmol/L dNTP and 0.1 unit of SuperTaq polyme-
rase (HT Biotechnology LTD, Cambridge, UK). 
Oligonucleotid primers were as described by Lane et al57. The reaction components were 
incubated at 94°C for 4 minutes, followed by 32 cycles of 94°C for 1 minute, 59°C for 
1.5 minutes and 72°C for 2 minutes. 
Ten uL of PCR product were digested with 5 units of Mspl (Gibco BRL, Life 
Technologies Inc., Gaithersburg, USA) at 37°C overnight. The digestion products were 
separated by electrophoresis through a 2% agarose gel in 44 mmol/L Tris/borate, 1 
mmol/L EDTA, containing 0.4 ug/mL etidiumbromide and visualized using UV light. 
Mspl digestion yielded a constant band of 40 base pair (bp). The common R allele gave 
bands of 205 bp and 67 bp and the Q353 allele gave a band of 282 bp as described 
previously23. 
Data analysis 
The association of FVILC and FVIIt with dietary factors was examined by means of 
multiple linear regression analysis using the BMDP-statistical package"6. For these 
analyses the quintile groups were combined. Adjustments were made for age and energy 
intake by including them as an independent variable in the regression model. 
To investigate whether the association of FVILC and FVIIt with dietary factors varies 
across the genotypes, the same analyses were carried out separately in those with RR 
genotype and those with RQ/QQ genotypes. As there were only 32 persons with the QQ 
genotype, they were combined with those with the RQ genotype for this analysis. 
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Table 4.1. Characteristics and dietary intake of the study population (mean ± SD) 
Lowest quintile 
(n=538) 
Highest quintile 
(n=575) 
Age (years) 
% Women 
Body mass index (kg/m2) 
FVII:C (%PP) 
FVIIt (%PP) 
Frequency Q allele 
Energy (MJ) 
Protein (g) 
Carbohydrates (g) 
Total fat (g) 
saturated fat (g) 
monounsaturated fat (g) 
polyunsaturated fat (g) 
Fibre (g) 
66.9 ± 7.8 
60.0 
25.7 ± 3.7 
85.0 ± 12.4 
69.1 ± 15.6 
0.24 (0.22,0.27) 
8.3 ±2.1 
81.0 ± 19.7 
213.3 ± 60.9 
80.9 ± 27.7 
31.7 ± 11.7 
27.6 ± 10.8 
15.5 ±7.8 
17.3 ± 5.8 
66.2 ±7.1 
55.2 
26.6 ± 3.3 
149.4 ± 17.1 
107.4 ±21.0 
0.09(0.07,0.11)* 
8.4 ± 2.2 
81.1 ± 19.0 
214.0 ±61.6 
82.4 ± 28.4 
32.4 ± 11.9 
28.2 ± 10.8 
15.5 ± 7.7 
16.7 ± 4.8 
95% confidence interval 
Results 
General characteristics and dietary intake of the study population are presented in Table 
4.1, for the lowest and the highest quintile separately. The characteristics that were also 
measured in the source population of 3005 people (i.e. age, body mass index and FVILC) 
were very similar to those of the study population of 1158 subjects (data not shown). In 
the lowest quintile 249 individuals (frequency 0.24) carried the Q353 allele and in the 
highest quintile 51 (frequency 0.05). In the total group FVILC was 35% lower (80.6 %PP 
versus 125.3 %PP) and FVIIt 48% (49.6 %PP versus 95.7 %PP) in individuals with the 
QQ genotype compared to those with the RR genotype (Table 4.2). The FVILC and FVIIt 
levels for those with the RQ genotype were intermediate. 
Table 4.3 shows the regression coefficients of factor VII and dietary factors for the total 
population. FVILC was inversely related to fibre intake (6=-0.64 %/g, CL-1.07,-0.21) and 
protein intake (6=-0.16 %/g, CL-0.31,-0.01). Adjustment for fat intake, did not change 
these results. Saturated fat intake was positively associated with FVILC (8=0.19 %/g, CL-
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0.10,0.48). FVILC was not associated with total energy intake, total fat intake and mono-
or polyunsaturated fat intake. FVIIt was inversely related to fibre intake (6=-0.38 %/g, 
CL-0.71,-0.05). No associations with any of the other dietary factors were found. 
Table 4.2. FVILC and FVIIt levels according to genotype (mean (SE)) 
RR RQ QQ 
FVILC (% PP*) total group 
lowest quintile 
highest quintile 
FVIIt (%PP*) total group 
lowest quintile 
highest quintile 
125.3 (1.2) 
n=858 
87.0 (0.6) 
n=334 
149.6 (0.7) 
n=524 
95.7 (0.9) 
n=829 
75.0 (0.8) 
n=325 
109.0 (0.9) 
n=504 
94.2 (1.7) 
n=268 
82.8 (0.9) 
n=218 
144.0(2.1) 
n=50 
68.2 (1.1) 
n=262 
62.7 (0.9) 
n=213 
92.1 (12.6) 
n=49 
80.6 (5.1) 
n=32 
76.2 (2.7) 
n=31 
215.0 
n=l 
49.6 (1.9) 
n=31 
49.4 (1.9) 
n=30 
55.5 
n=l 
FVII:C and FVIIt were measured with different pooled plasma's 
To explore these relations further we examined the associations of the three dietary factors 
with factor VII separately for the genotype groups. As the association of diet with factor 
VII was in similar direction in individuals with the RQ and QQ genotype (data not shown) 
and because the group of individuals with the QQ genotype was too small for meaningful 
regression analysis, the group with the QQ genotype was combined with the group with 
the RQ genotype. The results are presented in Table 4.4. In individuals with the RQ/QQ 
genotype the associations of FVILC with the dietary factors were weaker compared to 
those with the RR genotype. For fibre and protein there was no association in individuals 
with the Q353 allele and for saturated fat the association was reversed. 
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Table 4.3. Regression coefficients and 95% confidence intervals (95% CI) of several 
dietary factors and factor VII* 
Energy (%PP/MJ) 
Protein (%PP/g) 
Total fat (%PP/g) 
Saturated fat (%PP/g) 
Monounsaturated fat (%PP/g) 
Polyunsaturated fat (%PP/g) 
Fibre (%PP/g) 
FVILC 
6 
0.20 
-0.16 
0.07 
0.19 
0.09 
-0.04 
-0.64 
95% CI 
-0.80,1.00 
-0.31,-0.01 
-0.08,0.22 
-0.10,0.48 
-0.22,0.40 
-0.35,0.27 
-1.07,-0.21 
FVIIt 
6 
-0.20 
-0.004 
0.05 
0.09 
0.003 
0.09 
-0.38 
95% CI 
-0.98,0.58 
-0.12,0.11 
-0.07,0.17 
-0.13,0.31 
-0.25,0.26 
-0.16,0.34 
-0.71,-0.05 
Adjusted for age and sex. When intake in grams was used in the model, also adjustments were made for 
total energy intake. The regression coefficients indicate the change in factor VII in percent pooled plasma per 
unit change in nutrient intake. 
Table 4.4. Regression coefficients and 95% confidence intervals (95% CI) of protein, 
saturated fat and fibre intake and factor VII according to genotype* 
FVILC FVIIt 
Protein (%PP/g) 
Saturated fat (%PP/g) 
Fibre (%PP/g) 
RR 
RQ/QQ 
RR 
RQ/QQ 
RR 
RQ/QQ 
B 
-0.22 
-0.01 
0.35 
-0.40 
-0.76 
-0.19 
95% CI 
-0.40,-0.04 
-0.25,0.23 
0.02,0.68 
-0.87,-0.07 
-1.23,-0.29 
-0.97,0.59 
6 
-0.01 
-0.0004 
0.23 
-0.28 
-0.46 
-0.15 
95% CI 
-0.15,0.13 
-0.14,0.14 
-0.005,0.47 
-0.59,0.03 
-0.63,-0.11 
-0.66,0.36 
* All models adjusted for age, sex and total energy intake. The regression coefficients 
denote the change in factor VII in percent pooled plasma per unit change in nutrient 
intake. 
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For FVIIt there was a positive association with fibre in subjects homozygous for the R 
allele and no association in those with the RQ/QQ genotype. Although there was a 
negligible association between saturated fat and FVIIt in the total group, a positive associ-
ation was observed in individuals with the RR genotype, while an inverse association was 
found in individuals with the RQ/QQ genotype. When we adjusted the regression models 
for belonging to the lowest or highest quintile, the results were similar. 
Discussion 
In this study FVILC was in the total group inversely associated with fibre and protein 
intake and positively with saturated fat. In subjects with the RQ/QQ genotype these 
associations were weaker and for saturated fat the association was inverse. FVIIt was 
inversely associated with fibre intake and, in subjects with the RR genotype, also 
positively with saturated fat. 
In an unselected population the frequency of the Q353 allele is expected to be 0.1014123. If 
there is a direct relation between the R/Q353 polymorphism and the level of FVILC, a 
similar frequency would be expected in our population of extreme quintiles of the 
distribution of FVILC. The frequency in total population of 1158 subjects was, however, 
0.14. This suggests that another factor, linked to the R/Q353 polymorphism, is associated 
with FVILC. 
There have been several intervention studies in which the effect of diet on factor VII was 
studied. Marckmann and colleagues75,76 have reported a reduction in FVILC after a low-
fat/high-fibre diet compared to a high-fat/low-fibre diet in young and middle-aged 
subjects. No difference in FVIIt between both diets was observed. In one intervention 
study among diabetic patients, FVILC was almost 23% lower on a high-fibre diet 
compared to a low-fibre diet. The results from our study suggest that dietary fibre in older 
men and women is related to FVILC as well as FVIIt; an increase in fibre intake of 10 g 
(an increase that would raise the mean fibre intake towards the level of the current Dutch 
Guidelines for Healthy Eating"7) would result in a decrease of FVILC by 6.4 %PP and of 
FVIIt by 3.8 %PP. It is however important to notice that the regression coefficient may be 
overestimated as we included only the extreme quintiles of the distribution of factor VIIc. 
In several studies FVILC decreased after a low-fat diet compared to a high-fat diet2025'36. 
No difference was observed between diets with different fatty acid composition20'54'78,80. In 
our study only an association with saturated fat was found. One explanation may be that in 
intervention studies the intake of different fatty acids is usually much higher than it would 
be in a habitual diet. Another difference is that in our study blood samples were collected 
in a non-fasting state at a non-standardized moment, while in intervention studies samples 
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were collected in the fasting state. However, when we adjusted the associations for the 
time since the last meal before blood sampling, the results were similar. 
A possible mechanism behind the relation of dietary fat and fibre with FVILC may be 
found in the positive association of FVILC with serum triglycerides as reported 
previously'20; serum triglycerides are lowered by fibre intake and directly increased by fat 
intake28125. The associations of factor VII with the three dietary factors all varied between 
the genotype groups of the R/Q353 polymorphism. To our knowledge no other studies on 
diet and factor VII have been published which included assessment of the R/Q353 
polymorphism. Some evidence is available that the association between factor VII and 
serum-triglycerides is influenced by the R/Q353 polymorphism. In two studies a positive 
association between factor VII and triglycerides was found in individuals with the RR 
genotype but no association in those with the Q allele57,58. As the association of factor VII 
with dietary fat and with dietary fibre may both be mediated through serum-triglycerides, 
it could be expected that the influence of the R/Q353 polymorphism is also found in the 
association of factor VII with diet. It is, however, important to note that the individuals 
with the RQ genotype were combined with those with the QQ genotype, because of small 
numbers in the latter group. Theoretically the association of factor VII with dietary factors 
may be different if analyzed in each genotype group separately. Furthermore the R/Q353 
polymorphism is strongly linked to the -3231ns 10 polymorphism, which is suggested to be 
the functional polymorphism107124. 
In combination with tissue factor, factor VII is a very potent procoagulant, and high levels 
may increase the risk of a thrombotic event. The RR genotype of the R/Q353 
polymorphism of factor VII is a risk indicator for myocardial infarction through increased 
factor VII levels. This risk may be especially important in an environment of a high 
saturated fat/low-fibre and protein diet. 
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Coagulation factor VII, serum-triglycerides and the R/Q353 
polymorphism: differences between older men and women 
Abstract 
Coagulation factor VII activity (FVII:C) is a risk indicator for cardiovascular disease. It is 
related to serum-triglycerides, and the R/Q353 polymorphism (alleles R and Q) in the gene 
coding for factor VII is strongly associated with factor VII. The association of serum-
triglycerides with factor VII may differ between the genotypes, but the results of earlier 
studies were inconsistent and did not include older people. We studied FVII, triglycerides 
and the R/Q353 polymorphism in the Rotterdam Study. 
In 1158 older subjects (489 men and 669 women) FVILC, factor Vllt, serum-triglycerides 
and the R/Q353 genotype were determined. 
In women triglycerides were positively associated with FVIIt and FVILC (FVIIt: 6=12.4 
%PP/mmol/L, CI: 10.3-14.5; FVILC: 6=13.1 %PP/mmol/L, CI: 10.4-15.8). These 
associations varied by genotype (FVIIt: RR: 6=11.7, CI: 9.6-13.8, RQ/QQ: 6=7.9, CI: 4.6-
11.2; FVILC: RR: 6=12.5, CL9.5-15.5, RQ/QQ: 6=6.4, CL1.4-11.4). 
In men the associations of FVIIt and FVILC with triglycerides were weaker (FVIIt: 6=5.9, 
CL4.1-7.7; FVILC: 6=8.7, CL6.2-11.2). There was no difference between the genotype 
groups. 
These results suggest that only in older women the strength of the association of factor 
VII with serum-triglycerides varies according to genotype of the R/Q353 polymorphism. 
L.I. Mennen, M.P.M. de Maat, E.G. Schouten, C. Kluft, P.T.V.M. de Jong, A. Hofman, 
D.E. Grobbee 
Thromb Haemost 1997;78 (in press) 
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Introduction 
Increased factor VII coagulant activity (FVII:C) is associated with an increased risk of 
heart disease'"9. Therefore, interest in determinants of factor VII has grown. The R/Q353 
polymorphism in the gene coding for FVII is the result of a single base change in the 
codon for amino acid 353, leading to the replacement of arginine (R) by glutamine (Q)23. 
Presence of the Q allele is related to lower levels of FVILC and total factor VII23. 
In several studies serum-triglyceride concentration was positively associated with 
FVILC37'38-94'97 and with total factor VII16-40. As the R/Q353 polymorphism has a substantial 
influence on the level of both FVILC and total factor VII'21, the association of 
triglycerides with factor VII may differ between the genotypes. In a few studies this was 
investigated, however results are difficult to interpret, since subjects differed in ethnic 
background, disease status and gender57,58105''26'27. Furthermore, sample sizes were too 
small to account for the low frequency of the Q allele (0.099)'24. Although the 
thrombogenic potential of factor VII may be especially important in older people among 
whom atherosclerosis is common, none of these studies included elderly subjects. The 
Rotterdam Study, a population-based study, gave the opportunity to evaluate factor VII, 
serum-triglycerides and the R/Q353 polymorphism in a large cohort of Caucasian men and 
women, where adequate representation of the Q allele could be ensured by selecting the 
upper and lower quintile of the FVILC distribution. 
Subjects and methods 
The Rotterdam Study is a population-based study among 7983 subjects of 55 years and 
over"'. Subjects with myocardial infarction in the year before the investigation, diabetes 
mellitus, use of anticoagulants or stasis during venepuncture were excluded, leaving 3005 
subjects. None of the female subjects used hormone replacement therapy. 
FVILC was measured in non-fasting blood samples with a one-stage-clotting assay using 
human thromboplastin (Tromborel S, Behringwerke, Germany) and factor VH-deficient 
plasma (Ortho Diagnostic System, Beerse, Belgium). The results are expressed as 
percentages of pooled plasma (%PP). Individuals in the extreme quintiles of the FVILC 
distribution were selected (n=1158), expecting an enrichment for the Q allele (i.e. subjects 
with the RQ or QQ genotype) in the lowest quintile. In plasma of these persons total 
factor VII (FVIIt) was estimated by a two-stage amidolytic micro-titre assay 
(Chromogenix, Molndal, Sweden)122. Different pooled plasma's were used for the 
measurement of FVILC and FVIIt. Serum-triglycerides were measured with a colorimetric 
assay using a Kodak Ektachem 250 Analyzer. 
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DNA polymorphisms were determined as described previously124. Briefly, genomic DNA 
was amplified using PCR with oligonucleotid primers as described by Lane et al57. The 
reaction components were incubated at 94°C for 4 minutes, followed by 32 cycles of 94°C 
for 1 minute, 59°C for 1.5 minutes and 72°C for 2 minutes. Ten ul PCR product were 
digested with 5 units of Mspl (Gibco BRL) at 37°C. Mspl digestion yielded a constant 
band of 40 base pair (bp). The common R allele gave bands of 205 bp and 67 bp and the 
Q allele gave a band of 282 bp as described previously23. 
Complete data were available for 669 women and 489 men. Differences between the lower 
and the upper quintile, and between genotype groups were compared with the Student T-
test. The relation of FVII:C and FVIIt with serum-triglycerides was examined using linear 
regression analyses, separately for men and women, with age and body mass index as 
possible confounders. Since adjustment of the regression models for belonging to the 
lowest or highest quintile did not change the results, the quintiles were combined. The 
same analyses were carried out separately for genotype groups. As the association of 
triglycerides with factor VII was in the same direction in individuals with the RQ and QQ 
genotype and because the group of individuals with the QQ genotype was too small 
(n=32) for meaningful analyses, all individuals carrying the Q allele were combined in one 
group. 
Results and discussion 
As the results for men and women were different and combined interpretation may not be 
appropriate, they are given separately. 
Men 
There was no difference between the lowest and the highest quintile of FVII:C in age 
(mean (SD): 67.3 (7.2) vs 65.8 (6.7) years). In the lowest quintile the frequency of the Q 
allele was 0.25 and triglyceride concentration was 1.8 (0.8) mmol/L, in the highest quintile 
this was 0.06 and 2.5 (1.4) mmol/L. In the total group FVIIt was 48 %PP and 88 %PP for 
men with the QQ and RR genotype respectively, and FVILC was 85 %PP and 119 %PP 
(Table 5.1 A). FVIIt and FVILC were both positively associated with serum-triglycerides 
(Table 5.2A). For FVIIt there was no difference between the genotype groups. For FVILC 
there was a trend towards a stronger association with triglycerides in men carrying the Q 
allele. 
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Table 5.1. FVILC and FVIIt (mean ± SE) per genotype for men (A) and women (B). 
A. Men 
Total group Lowest quintile Highest quintile 
FVIIt* 
FVILC* 
RR 87.8 ± 1.1 (n=337) 68.8 ± 1.2 (n=122) 98.6 ± 1.1 (n=215) 
RQ 64.3 ± 1.6 (n=121) 57.6 ± 1.2 (n=93) 86.6 ± 2.8 (n=28) 
QQ 48.2 ± 1.8 (n=12) 47.5 ± 1.9 (n=ll) 55.5 (n=l) 
RR 119.0 ± 1.7 (n=352) 79.7 ± 0.7 (n=127) 140.5 ± 1.0 (n=225) 
RQ 90.6 ± 2.5 (n=125) 76.7 ± 1.0 (n=96) 136.6 ± 2.5 (n=29) 
QQ 85.4 ± 1.2 (n=12) 73.6 ± 2.4 (n=ll) 215.0 (n=l) 
B. Women 
FVIIt* 
FVILC* 
RR 
RQ 
QQ 
RR 
RQ 
QQ 
Total group 
101.1 ± 1.2 (n=492) 
71.5 ± 1.5 (n=141) 
50.5 ± 2.8 (n=19) 
129.9 ± 1.5 (n=506) 
97.4 ± 2.3 (n=143) 
77.7 ± 4.0 (n=20) 
Lowest quintile 
78.8 ± 1.0 (n=203) 
66.6 ± 1.1 (n=120) 
50.5 ± 2.8 (n=19) 
91.5 ± 0.8 (n=207) 
87.6 ± 1.2 (n=122) 
77.7 ± 4.0 (n=20) 
Highest quintile 
116.7 ± 1.2(n=289) 
99.5 + 1.9 (n=21) 
156.3 ± 0.8 (n=299) 
154.4 ± 2.2 (n=21) 
FVH:C and FVIIt are presented in %PP, different pooled plasma's were used 
Humphries et al58 reported in a group of Caucasian males a positive association between 
FVIIt and triglycerides in men homozygous for the R allele and a weaker association for 
men carrying the Q allele. Saha et al105 studied Dravidian Indians and observed a positive 
association in both genotype groups, the association being stronger in subjects carrying the 
Q allele. Several differences between these study populations, like ethnic background, diet 
and inclusion of women, may explain the difference in results. In our study among older 
men the association of FVIIt with triglycerides was confirmed both in those with the RR 
genotype and in those carrying the Q allele. We conclude that no major differences 
between the genotypes of the R/Q353 polymorphism in the association of FVIIt and 
triglycerides are present in Dutch elderly men. 
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Table 5.2. Regression coefficients and 95% confidence intervals (95% CI) of triglycerides 
on FVILC and FVIIt by genotype for men (A) and women (B)*. 
A. Men 
FVIIt FVILC 
6 95% CI fi 95% CI 
Total group 5.9 4.1,7.7 8.7 6.2,11.2 
RR 5.5 3.7,7.3 7.3 4.6,10.0 
RQ/QQ 5.7 2.7,8.7 10.8 5.8,15.7 
B. Women 
FVIIt FVILC 
B 95% CI fi 95% CI 
Total group 12.4 10.3,14.5 13.1 10.4,15.8 
RR 11.7 9.6,13.8 12.5 9.5,15.5 
RQ/QQ 7.9 4.6,11.2 6.4 1.4,11.4 
All models adjusted for age and body mass index. The regression coefficients give the change in FVIIt and 
FVTI:C in percent pooled plasma per unit change in triglycerides (%PP/mmol/L). 
Interpretation of results on FVILC are more complicated, since it is increased immediately 
after fat intake and samples can be taken in fasting and postprandial state'07. In our study 
samples were taken throughout the morning and afternoon, but adjustment for time since 
last meal did not change the results, suggesting that postprandial effects of the Dutch light 
breakfast and lunch are limited. This may be different in other populations with different 
ethnic background and dietary habits. The relation between FVILC and triglycerides did 
not differ between the genotype groups in our study. The same was observed in a study 
among Caucasian patients with non-insulin-dependent-diabetes mellitus, where fasting 
blood samples were taken126. Humphries et al58 observed a positive association between 
non-fasting FVILC and triglycerides in Caucasian males with the RR genotype, but not in 
those carrying the Q allele. Similar results were observed in Gujarati Indians by Lane et 
al57. In Dravidian Indians, however, the association between fasting FVILC and 
triglycerides was only found in those carrying the Q allele105. The discrepancies in these 
results may be ascribed to the different prandial states and the differences in dietary habits 
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between the study populations. Furthermore, if the relation between FVII:C and 
triglycerides depends on the amount of activated factor VII in the sample, different results 
will be expected between essays for FVILC which differ in sensitivity towards activated 
factor VII44. This could thus be another explanation for the discrepancy in findings 
between the studies described. Further analysis in larger groups and with specific attention 
to the prandial state and the essay used to measure factor VII is required. 
Women 
There was no difference between the lowest and the highest quintile of FVILC in age 
(mean (SD): 66.8 (8.2) vs 66.6 (7.3) years). In the lowest quintile the frequency of the Q 
allele was 0.23 and triglyceride 1.7 (0.7) mmol/L, in the highest quintile this was 0.03 and 
2.4 (1.1) mmol/L. In the total group FVIIt was 51 %PP and 101 %PP for women with the 
QQ and RR genotype respectively, and FVILC was 78 %PP and 130 %PP (Table 5.1B). 
The triglyceride concentration was positively associated with FVIIt and FVILC (Table 
5.2B). The regression coefficients were almost twice as high in women with the RR 
genotype, compared to women carrying the Q allele (p<0.05 for interaction) and they were 
larger compared to those found in men. 
No substantial data on the relation of triglycerides with factor VII between genotype 
groups in women are available. In our study we observed a stronger relation of both FVIIt 
and FVILC with triglycerides in RR homozygotes, while these associations in Q allele 
carriers was similar to that in men. These results suggest that the regulation of the factor 
VII metabolism by the R allele is different in women compared to men. Support for this 
view is given by Meilahn et al127, who observed a post-menopausal increase in FVILC 
only in women homozygous for the R allele and not in those carrying the Q allele. This 
may explain why they did not find a genotype-triglycerides interaction in the total group 
of pre- and postmenopausal women. In conclusion, our findings suggest, that at least in 
postmenopausal women the triglyceride status may contribute in those with the RR 
genotype to an increased risk for myocardial infarction, provided that the risk observed in 
epidemiological studies in men also applies to women. 
General 
Humphries et al58 previously discussed the impact of the interaction of triglyceride status 
and the R/Q353 polymorphism in relation to the risk of myocardial infarction. Our present 
data strongly suggest to pay specific attention to gender differences. The impact of genetic 
variation in factor VII may obviously be quite distinct in populations which differ in life 
style. The possibility that both genetically susceptible groups and life style elements can 
be identified as risk determinants may open possibilities for targeted prevention. 
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Factor Vila response to a fat-rich meal does not depend on fatty 
acid composition: A randomized controlled trial 
Abstract 
A fat-rich meal increases FVIIa, but it is not clear whether this increase depends on the 
fatty acid composition of the meal. Therefore, we studied the FVIIa response to fat-rich 
meals with different fatty acid composition in a randomized controlled cross-over trial and 
investigated whether this response is mediated by an increase in serum-triglycerides. 
Elderly women (> 60 years, n=91) received on separate days four different fat-rich 
breakfasts (50 energy % of fat) and a control breakfast (1.5 en% fat) (cross-over). The fat-
rich breakfasts differed in fatty acid composition: one rich in palmitic acid (21.7 g), one in 
stearic acid (18.6 g), the other two in linoleic and linolenic acid one with a ratio 3:1 
(12.5/3.9 g) and another with a ratio of 15:1 (18.8/1.2 g). At 8.00 AM before the breakfast 
(fasting) and at 1.00 and 3.00 PM blood samples were taken, in which FVIIa and serum-
triglycerides were measured. 
FVIIa response to the fat-rich meals ranged from 11.6 IU/mL (95% confidence interval: 
8.3,14.9) on the stearic meal to 15.9 IU/mL (12.0,19.8) on the linoleic/linolenic 15:1 meal 
at 1.00 PM and from 14.9 IU/mL (10.6,19.2) to 21.1 IU/mL (16.6,25.6) for the same 
meals at 3.00 PM. The responses did not differ between the fat-rich meals. After the 
control breakfast FVIIa decreased with 6.3 IU/mL (3.9,8.7) at 1.00 PM and with 8.7 
IU/mL (6.3,11.1) at 3.00 PM. The triglyceride response was lower after both 
linoleic/linolenic rich breakfasts compared to the palmitic and stearic breakfast (p<0.05) 
and was not associated with the FVIIa response at any of the blood sampling occasions. 
The results of this study show that the response of FVIIa to a fat-rich meal is independent 
of its fatty acid composition and is not mediated by serum-triglycerides. 
L. Mennen, M. de Maat, G. Meijer, P. Zock, D. Grobbee, F. Kok, C. Kluft, E. Schouten 
Submitted for publication 
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Introduction 
Factor VII is a vitamin K-dependent coagulation factor, which circulates in plasma mainly 
as an inactive zymogen. About one percent of this factor VII circulates in the activated 
form, factor Vila (FVIIa). A small increase in FVIIa may, at release of tissue factor, lead 
to an explosive formation of thrombin and thereby, to an increase in the risk of arterial 
occlusion. This risk may be even more important in elderly people, where the prevalence 
of atherosclerosis is high. 
FVIIa can be measured directly, but also the coagulant activity of factor VII (FVILC) can 
be measured. Since the direct measurement of FVIIa became only recently available, 
FVILC was often used in previous studies. This measurement, however, does not only 
reflect FVIIa, but also an unknown part of factor VII zymogen. Furthermore, different 
reagents hamper comparability of these studies. In two longitudinal studies a positive 
association between FVILC and fatal ischaemic heart disease was observed2,6. It is by now 
accepted that FVILC increases postprandially after intake of dietary fat120. It is however 
not yet clear whether this increase is dependent on fatty acid composition of the fat 
consumed. Five studies have evaluated this for FVILC, but the results were contradicting 
and sample sizes were small (n=4-10)28'32'92128'129. In a few experimental studies, also a 
post-prandial increase in FVIIa has been observed106130"'32, but none of these studies 
investigated different fatty acids. Furthermore, FVIIa is higher in post-menopausal women 
compared to men of the same age13, but (elderly) women have rarely been included in 
studies on FVIIa and dietary fat. 
One of the mechanisms which may explain an effect of dietary fat on factor VII is based 
on activation of factor VII during lipolysis of triglyceride rich lipoproteins70120. In two 
studies a positive association between postprandial concentrations of serum-triglycerides 
(which partly reflect the amount of triglyceride rich lipoproteins) and factor VII was 
observed28106. 
We studied the FVIIa and serum-triglyceride response to fat-rich meals with different fatty 
acid composition in a randomized controlled cross-over trial in a large number of 
apparently healthy elderly women. 
Subjects and methods 
Subjects 
Elderly women, living independently in retirement communities in the surroundings of 
Wageningen, the Netherlands, were invited to participate in the study. They had to fulfil 
the following inclusion criteria: older then 60 years of age, no diabetes mellitus, no 
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myocardial infarction in the year before the investigation, no use of vitamin K-antagonists, 
no use of hormone replacement therapy, no medical problems after fat consumption. For 
purpose of a separate research question subjects were selected on the genotype of the 
R/Q353 polymorphism of the gene coding for factor VII, in order to have comparable 
numbers of subjects in each genotype group. In total 96 women entered the study. One 
participant dropped out because of illness and four because not enough blood could be 
sampled. At the end of the study complete data were available of 91 participants (35 with 
the RQ or QQ genotype and 56 with RR). The study was approved by the Medical Ethics 
Committee of the Agricultural University Wageningen and written informed consent was 
obtained from all participants. 
Height and weight were measured and body mass index was calculated by dividing weight 
by the square of height (kg/m2). Blood pressure was measured with the subject in 
recumbent position, three times at five minutes intervals. The mean of the last two 
measurements was taken as the mean blood pressure. The habitual fat intake was estimated 
with a validated food-frequency questionnaire133. The general characteristics of the study 
population are presented in Table 6.1. 
Table 6.1. General characteristics of the female study population (n=91) 
MEAN SD 
Age (years) 
Body mass index (kg/m2) 
Systolic blood pressure (mmHg) 
Diastolic blood pressure (mmHg) 
Total cholesterol (mmol/L)* 
Serum-triglycerides (mmol/L)* 
Factor Vila (IU/mL)* 
Current smoking (%) 
the levels are from fasting blood samples 
Intervention Procedure 
Every participant received each of the five different breakfasts with at least one week in 
between, in different order (cross-over). For each participant every test was performed on 
the same day of the week. For practical reasons there were no tests on Mondays or on 
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75.7 
27.7 
141.6 
72.5 
6.03 
1.7 
75.2 
7.7 
5.2 
4.1 
19.4 
9.5 
0.86 
0.67 
32.1 
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weekends. 
Participants gathered in the communal room in their apartment building at 8.00 AM after 
an overnight fast. Within half an hour after taking blood samples with minimal stasis, they 
ate their breakfast. At 1.00 PM and 3.00 PM subsequent blood samples were taken. The 
participants remained in the communal room during the whole procedure and went home 
after the last blood sampling. At 10.00 AM and 2.00 PM coffee or tea with a fat free 
snack were served and at noon a fat free lunch. Except for the breakfast they were free to 
choose from the fat free foods (fruits, fat-free cake and fat-free bread) we supplied, but 
were not allowed to eat anything else. 
Table 6.2. Analyzed fat composition of the breakfasts 
kJ+ 
Fat g 
Fat en%+ 
CI 6:0s 
C18:0S 
C18:l* 
C18:2S 
C18:3S 
Palmitic 
3966 
55.7 
53 
21.7 
3.2 
20.4 
7.6 
0.2 
Stearic 
3721 
49.3 
50 
4.9 
18.6 
18.6 
5.2 
0.1 
Linol 3:1* 
3798 
51.4 
51 
5.8 
3.9 
22.1 
12.5 
3J> 
Linol 15:1* 
3815 
51.5 
51 
5.3 
3.9 
20.0 
18.8 
LI 
Control 
3657 
1.5 
1.5 
0.3 
0.06 
0.2 
0.7 
0.05 
The underlined numbers show the fat exchange between the breakfasts 
Linol 3:1 = linoleic/linolenic acid in ratio 3 to 1 
Linol 15:1 = linoleic/linolenic acid in ratio 15 to 1 
calculated 
s
 In grams per breakfast, C16:0 = palmitic acid, C18:0 = stearic acid, C18:l = oleic acid, C18:2 = linoleic 
acid, C18:3 = linolenic acid 
Breakfast 
At each day the participants received a different breakfast with similar total energy 
content. Four breakfasts contained 50 energy percent (en%) of fat (fat-rich breakfast), the 
control breakfast only 1.5 en% of fat (Table 6.2). In the control breakfast fat was 
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exchanged for carbohydrates (46 en% vs 94 en% in fat-rich and control breakfast 
respectively). The fat-rich breakfasts differed in fatty acid composition: one was rich in 
palmitic acid (C16:0, 21.7 g), one in stearic acid (CI8:0, 18.6 g), the other two in linoleic 
(C18:2) and linolenic acid (C18:3), one with a ratio 3:1 (12.5/3.9 g) (linol 3:1) and another 
with a ratio of 15:1 (18.8/1.2 g) (linol 15:1). 
The fat-rich breakfasts consisted of a high-fat bun with 20 g margarine (90% fat) and 30 g 
jam, 200 mL orange juice and 67 g cake. The control breakfast consisted of a low-fat bun 
with 10 g low-fat spread (3% fat) and 30 g jam, 200 mL low-fat yoghurt mixed with 65 g 
carbohydrate rich powder, containing 62.4 g carbohydrates (caloreen, Clintec Utrecht), 20 
g sugar, one cup of tea and 100 mL carbohydrate rich drink, containing 31 g 
carbohydrates (nutrical, Nutricia Zoetermeer). Each participant received the breakfasts in a 
different order. 
Laboratory measurements 
Blood was collected in siliconized vacutainer tubes containing 0.129 mol/L sodium citrate 
(Becton Dickinson). The first 5 mL were used for measurement of blood lipids. Samples 
were centrifuged for 30 minutes at 1500 x g and 20CC. Citrated plasma was snap frozen 
and stored at -80°C until laboratory analysis. FVIIa was measured in all samples on the 
STA instrument (Boehringer, Germany), with a clotting assay using soluble recombinant 
tissue factor (Staclot, Diagnostica Stago, France)60. The recorded clotting time is inversely 
related to the FVIIa level (expressed in IU/mL). Serum-triglycerides were measured with a 
colorimetric assay using a Kodak Ektachem 250 Analyzer. Serum total cholesterol was 
determined using an automated enzymatic procedure"5. 
Data analysis 
For every participant the five fasting measurements were combined to calculate the mean 
fasting FVIIa, triglycerides and total cholesterol concentration in the study population. 
The response of FVIIa at each meal was calculated by subtraction of the fasting FVIIa 
level from the levels at 1.00 PM and 3.00 PM. To determine whether average response on 
a type of breakfast differed from zero, 95% confidence intervals (CI) were computed. 
Multiple comparisons were made with the Tukey test to investigate whether the FVIIa 
response differed between the fat-rich breakfasts. 
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Figure 6.1. Response of FVIIa for each breakfast separately 
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Results 
The FVIIa responses did not differ between the fat-rich breakfasts (Figure 6.1). FVIIa 
response to the fat-rich meals ranged from 11.6 IU/mL (95% confidence interval: 8.3,14.9) 
on the stearic meal to 15.9 IU/mL (12.0,19.8) on the linoleic/linolenic 15:1 meal at 1.00 
PM and from 14.9 IU/mL (10.6,19.2) to 21.1 IU/mL (16.6,25.6) for the same meals at 
3.00 PM. When the results on the fat-rich breakfast were combined, FVIIa increased from 
74.9 IU/mL (SD: 32.3) to 88.4 IU/mL (SD: 38.6) at 1.00 PM and to 93.0 IU/mL (SD: 
41.0) at 3.00 PM (mean response at 3.00 PM: 19.5 IU/mL (15.8,23.2)). After the control 
breakfast FVIIa decreased with 6.3 IU/mL (3.9,8.7) at 1.00 PM and with 8.7 IU/mL 
(6.3,11.1) at 3.00 PM. The mean difference between the FVIIa response to the four fat-
rich breakfasts combined and the response to the control breakfast in the 3.00 PM sample 
was 28.0 IU/mL (CI: 24.1,31.9). 
After the control breakfast triglycerides concentration increased slightly up to 1.77 mmol/L 
(SD:0.89) in the 3.00 PM sample. The triglycerides responses on the fat-rich breakfasts 
were highest in the 1.00 PM sample, but were still elevated in the 3.00 PM sample (Figure 
6.2). The triglyceride level at 1.00 PM after the palmitic breakfast was 3.44 mmol/L (SD: 
1.64) and after the stearic breakfast 3.38 mmol/L (SD: 1.60), while the level was lower 
after the linol 3:1 (3.07 mmol/L, SD: 1.50) and linol 15:1 breakfast (3.03 mmol/L, SD: 
1.63). The difference at 1.00 PM between the palmitic and stearic breakfast compared to 
linol 3:1 and 15:1 breakfast ranged from 0.28 mmol/L for stearic vs linol 15:1 to 0.39 
mmol/L for palmitic vs linol 3:1 (p<0.05 for differences between breakfasts). There was 
no association between the response of FVIIa and the response of triglycerides at any of 
the blood sampling occasions. 
Discussion 
The results of this randomized controlled trial clearly demonstrate that the FVIIa increase 
in elderly women after a fat-rich breakfast is independent of the fatty acid composition of 
the meal. 
The breakfasts in our study contained a high amount of fat compared to what elderly 
people are used to eat at breakfast (approximately 15 g fat134), in order to maximize the 
chance of a FVIIa response. In fact, on a normal day FVILC would probably hardly start 
to rise until after lunch29. For feasibility reasons we decided to put the amount of fat 
usually eaten at breakfast and lunch together in one fat-rich breakfast. Therefore, this does 
not necessarily reflect the FVIIa change at these hours in a normal situation. 
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Figure 6.2. Response of serum-triglycerides for each breakfast separately 
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The participants in our study may have been a somewhat healthy selection of the general 
elderly population, because of the inclusion criteria we used in order to prevent 
interference by medication and disease. Additionally, the subjects were selected on 
genotype of the R/Q353 polymorphism. In a general population about 20% of the people 
carry the Q allele23, while in our study population 38% carried this allele. Since the FVIIa 
response to a fat-rich meal is lower in subjects carrying the Q allele than in those with the 
RR genotype135, the increase in FVIIa after a fat-rich meal as observed in our study, 
probably underestimates the true increase. Furthermore, only women were included in our 
study. Post-menopausal women have higher values of FVIIa compared to men of the same 
age13. It is, however, not yet known whether the response of FVIIa to a fat-rich meal in 
post-menopausal women is also higher than in men. 
For practical reasons it was not possible to obtain more than three blood samples per day 
in these elderly women. Although Figure 6.1 suggests that after the fat-rich breakfast, 
FVIIa is still rising at 3.00 PM, it is expected from the literature that the peak in the 
FVIIa response occurred at some point between 1.00 PM and 3.00 PM106128 '30-132. 
Table 6.3. Previous studies on the response of FVILC to a fat-rich meal 
REF 
28 
32 
92 
128 
129 
DIET* 
SAFA vs PUFA 
SAFA vs PUFA 
SAFA vs PUFA 
olive oil vs MCT fat 
C18:0 vs C14:0 
SUBJECTS 
5 men, 4 women, healthy 
10 men, middle-aged 
4 men, 1 women, healthy 
4 men, 2 women, age 22-43 
10 men, age 21-28 
FVII:C 
__# 
-
SAFA T* 
olive oil t 
M C T -
C18:0 T (ns8) 
C14:0 -
SAFA = saturated fat, PUFA = polyunsaturated fat, MCT = medium chain triglycerides, CI8:0 = stearic 
acid, C14:0 = myristic acid 
'—' = no difference 
'T' = increased 
k
 ns = non significant 
Five studies have been published in which the effect of fatty acid composition on FVII:C 
was investigated2832'92128129 (Table 6.3). In three studies the effect of FVILC to a meal rich 
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in saturated fat was compared to a meal rich in unsaturated fat28,32,92, but only in one of 
them a difference between the meals was found92. Sanders et al'28 compared a meal rich in 
olive oil with one rich in medium chain triglycerides and observed an increase in FVILC 
only after the olive oil meal. Stearic and myristic acid, both saturated fats, were compared 
in a study by Tholstrup et al129. Their results showed no increase after myristic acid and a 
minor increase after stearic acid, though this was not significant. 
A major difference between the studies is that in some of them FVILC was studied 
directly after a fat-load32128129, while in the others postprandial blood samples were taken 
on the final day of a one or four week diet28'92. The diet consumed in the period before the 
post-prandial test may influence the response of factor VII. However, in our study we did 
not find an association between nutrient intake of the habitual diet and the postprandial 
response of FVIIa. Summarizing, we think that the results of these small experimental 
studies combined with the results of our large trial support the view that the factor VII 
response to a high dietary fat intake is independent of the type of fat. 
One of the mechanisms which could explain the effect of dietary fat on factor VII 
involves triglyceride rich lipoproteins (TRLP)70. During lipolysis of TRLP factor VII 
becomes activated. In our study we measured serum-triglycerides as an estimate of 
circulating postprandial TRLP, but the concentration of serum-triglycerides was not 
associated with FVIIa. This was also observed in one previous study132. Silveira et al106, 
however, did observe a positive association between FVIIa and serum-triglycerides, 
measured six hours after a fat load. This discrepancy in results may indicate that either 
serum-triglycerides do not reflect TRLP or that triglycerides are not involved in the 
mechanism behind the relation between factor VII and dietary fat. 
FVIIa is a very potent coagulant, which in complex with tissue factor may induce 
thromboembolic occlusion of diseased blood vessels. The lower the circulating level of 
FVIIa, the lower the risk of atherothrombotic complications, especially in elderly persons. 
The postprandial rise of FVIIa should therefore be kept as low as possible. The results of 
our study show that this is best achieved by reducing the total amount of fat in the diet, 
rather than by changing fat composition. 
In conclusion, our study shows that in elderly women the FVIIa response to a fat-rich 
meal is not dependent on the fatty acid composition, and that this response is not mediated 
by a post-prandial increase in triglycerides. 
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Postprandial response of coagulation factor Vila varies across 
R/Q353 genotypes 
Abstract 
Activated factor VII (FVIIa) is, together with tissue factor, a very potent coagulant. The 
amount of circulating FVIIa at the time of a cardiovascular event, may be a key 
determinant of its outcome. The level of FVIIa is influenced by dietary fat intake and 
genetic factors. We have investigated whether the response of FVIIa to a fat-rich breakfast 
varies across genotypes of the R/Q353 polymorphism in the factor VII gene. 
In 321 elderly women (>60 years) the genotype for the R/Q353 polymorphism was 
assessed. Fiftyfour randomly selected women with the RR genotype and 37 women with 
the RQ or QQ genotype participated in the intervention study. Subjects received five 
breakfasts each on a separate day: one control breakfast (1,5 energy percent of fat (en%)) 
and four high-fat test breakfasts (50 en%). At 8.00 AM before each breakfast (fasting) and 
at 1.00 PM and 3.00 PM blood samples were taken for measurement of FVIIa. 
The mean fasting FVIIa level was 93.7 IU/mL (SD:26.5) in women with the RR genotype 
and 38.3 (SD:17.8) in those with the QQ genotype. The FVIIa response to the test 
breakfasts at 1.00 PM and 3.00 PM differed from the response to the control breakfast in 
both genotype groups. The mean absolute total response to all four test breakfasts was 
37.0 IU/mL in those with the RR genotype and 16.1 IU/mL in those carrying the Q allele 
(p<0.001 for difference). Likewise, the FVIIa response relative to the fasting FVIIa level 
was significantly higher in women homozygous for the R allele. 
FVIIa increases profoundly after a fat-rich meal in elderly women with the RR genotype 
for the R/Q353 polymorphism. This observation may indicate a considerable difference in 
cardiovascular risk between genotype groups concerning a fat-rich diet. 
L. Mennen, M. de Maat, G. Meijer, P. Zock, D. Grobbee, F. Kok, C. Kluft, E. Schouten 
Submitted for publication 
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Introduction 
Coagulation factor VII circulates in plasma mainly as an inactive zymogen, and about 1% 
of this circulates as activated factor VII (FVIIa). FVIIa is, together with tissue factor, a 
very potent coagulant, and it is conceivable that a small increase in FVIIa may lead to a 
pronounced elevation of the risk of a cardiovascular event. Until recently FVIIa could not 
be measured. Instead a functional clotting assay was used (factor VII:C), which reflects 
FVIIa and an unknown part of factor VII zymogen. In two longitudinal studies a positive 
association between factor VII:C and the risk of fatal ischaemic heart disease was 
observed2-6. 
In the gene coding for factor VII the R/Q353 polymorphism is the result of a single base 
change in the codon for amino acid 353 and leads to the replacement of arginine (R) by 
glutamine (Q)23. Presence of the Q allele is associated with low levels of factor VII23. 
Another major determinant of FVIIa is dietary fat intake. Several intervention studies, 
comprising mostly small numbers of middle-aged male subjects, have shown an increase 
of FVIIa after a fat-rich
 meal106'128130132. It is not yet clear whether this response of FVIIa 
to fat intake is affected by the R/Q353 polymorphism. 
We studied the FVIIa response to fat-rich meals in a large number of apparently healthy 
elderly women, who were selected on their genotype for the R/Q353 polymorphism. 
Subjects and methods 
Elderly women living independently in retirement communities were asked to participate 
in the study. The women had to fulfil the following inclusion criteria: older than 60 years 
of age, no diabetes mellitus, no myocardial infarction in the year before the investigation, 
no use of vitamin K-antagonist, no use of hormone replacement therapy, no medical 
problems after fat consumption. In 321 women the genotype for the R/Q353 
polymorphism was assessed. Thirtyfive out of the 55 women found to carry the Q allele 
were able to participate and fiftysix women with the RR genotype were randomly selected. 
Thus a total of 91 women were included in the intervention study. The study has been 
approved by the Medical Ethics Committee of the Wageningen Agricultural University and 
written informed consent was obtained from all participants. 
Participants received five breakfasts, each at a different day. At 8.00 AM (after an 
overnight fast) the first blood sample was taken and within half an hour the subjects ate 
their breakfast. At 1.00 PM and 3.00 PM additional blood samples were taken. The 
participants stayed in the same room during the whole procedure and received after the 
breakfast only fat free foods if wanted, and were not allowed to eat anything else. 
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All breakfasts had the same total energy content, but four breakfasts contained 50 energy 
percent (en%) of fat (test breakfast), while the control breakfast contained only 1.5 en% of 
fat (fat was exchanged for carbohydrates). The test-breakfasts consisted of a high-fat bun 
with 20 g margarine and 30 g jam, 200 mL orange juice and 67 g cake. The control 
breakfast consisted of a low-fat bun with 10 g low-fat spread and 30 g jam, 200 mL low-
fat yoghurt mixed with 65 g energy rich powder (caloreen, Clintec Utrecht), 20 g sugar, 
one cup of tea and 100 mL energy rich drink (nutrical, Nutricia Zoetermeer). For purpose 
of a separate research question the test-breakfasts differed in fatty acid composition. 
Blood was collected in siliconized vacutainer tubes containing 0.129 mol/L sodium citrate 
(Becton Dickinson). Samples were centrifuged for 30 minutes at 1500 x g and 20°C. 
Citrated plasma was snap frozen and stored at -80°C until laboratory analysis. FVIIa was 
measured on the STA instrument (Boehringer, Germany) with a clotting assay using 
soluble recombinant tissue factor (Staclot, Diagnostica Stago France)60. The clotting time 
recorded is inversely related to the FVIIa level (expressed in IU/mL). 
DNA was extracted from mouth swabs according to Meulenbelt et al136. DNA 
polymorphisms were determined as described previously124. Briefly, genomic DNA was 
amplified using PCR with oligonucleotide primers as described by Lane et al57. The 
reaction components were incubated at 94°C for 4 minutes, followed by 32 cycles of 94CC 
for 1 minute, 59°C for 1.5 minutes and 72°C for 2 minutes. Ten ul PCR product were 
digested with 5 units of Mspl (Gibco BRL) at 37°C. Mspl digestion yielded a constant 
band of 40 base pair (bp). The common R allele gave bands of 205 bp and 67 bp and the 
Q allele gave a band of 282 bp as described previously23. 
The response of FVIIa to each meal was calculated by subtraction of the fasting FVIIa 
level from the levels at 1.00 PM and 3.00 PM. Since the number of persons with the QQ 
genotype was too small for meaningful analysis, they were combined with subjects having 
the RQ genotype. Furthermore, the mean of the responses of FVIIa to the four test-
breakfasts was used in this study, as there was no difference in response of FVIIa between 
the test-breakfasts135. The mean absolute total response was calculated as the mean 
response to the test breakfasts at 3.00 PM minus the response to the control breakfast at 
3.00 PM. The mean relative total response is the mean absolute total response as a 
percentage of the fasting FVIIa level. With the Student T-test it was evaluated whether the 
response to the test breakfasts differed from the response to the control breakfast, and 
whether the mean absolute and relative total response differed between the genotype 
groups. To allow further adjustment for fasting level of FVIIa a linear regression analysis 
was performed with the mean absolute total response as dependent variable and the 
genotype group and fasting FVIIa level as independent variables. 
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Table 7.1. General characteristics according to genotype of the female study population 
(mean ± SD) 
Age (years) 
Body mass index (kg/m2) 
Systolic blood pressure 
Diastolic blood pressure 
Total cholesterol* 
Serum-triglycerides* 
Factor Vila (IU/mL)* 
Frequency Q allele* 
Total 
(n=91) 
75.7 ± 5.2 
27.7 ±4.1 
142 ± 19.4 
72 ± 9.5 
6.03 ± 0.86 
1.70 + 0.67 
75.2 ±32.1 
0.09 
RR 
(n=56) 
75.6 ± 5.2 
28.0 ± 3.9 
142 ±21.9 
73 ± 9.5 
6.12 ±0.86 
1.72 ±0.63 
93.3 ± 26.7 
RQ 
(n=32) 
76.0 ± 5.2 
27.4 ± 4.5 
142 ± 15.2 
71 ±9.0 
5.90 ± 0.87 
1.69 ± 0.76 
49.3 ± 19.1 
QQ 
(n=3) 
76.0 ±6.1 
26.1 ±4.5 
133 ± 18.6 
68 ± 17.8 
5.87 ± 0.34 
1.47 ±0.51 
39.5 ± 17.2 
fasting levels, lipids in mmol/L 
frequency in source population of 321 women 
Results 
General characteristics of the study population according to genotype are presented in 
Table 7.1. The frequency of the Q allele in the source population of 321 women was 0.09. 
Compared to women homozygous for the R allele, fasting FVIIa was 47% lower (49.3 
IU/mL vs 93.3 IU/mL) in women with the RQ genotype and 58% lower (39.5 IU/mL 
versus 93.3 IU/mL) in women homozygous for the R allele. 
The response of FVIIa to the test-breakfasts at 1.00 PM and at 3.00 PM differed from the 
response to the control breakfast, both for those with the RR genotype and those with the 
RQ or QQ genotype (Figure 7.1). The mean absolute total response of FVIIa was 37.0 
IU/mL in the group with the RR genotype and 16.1 IU/mL (p<0.001) in those carrying the 
Q allele. Notably, the R/Q353 polymorphism was an independent predictor of the FVIIa 
response even after adjustment for fasting FVIIa level in the linear regression model (8=-
11.8 (95% confidence interval: -20.0,-3.6). The mean relative total response in FVIIa was 
42% and 32% (p=0.01 for difference) in women homozygous for the R allele and those 
carrying the Q allele respectively. 
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Figure 7.1. Mean FVIIa levels after test and control breakfast according to genotype 
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Discussion 
The results of this study in elderly women clearly demonstrate that the absolute as well as 
the relative response to a fat-rich meal depend on the genotype of the R/Q353 
polymorphism. 
The subjects in this study were selected on genotype to get similar numbers of women 
with the RR and RQ or QQ genotype. The frequency of the Q allele in the source 
population of 321 women, however, was similar to the frequency previously reported in 
white Europeans57,58. 
In five earlier studies an increase in FVIIa was found after a fat-rich meal'06'128130"132. 
Miller et al130 observed a 19% increase in FVIIa six and a half hour after a high-fat (64 
en% of fat) meal and no response to a low-fat (9 en% of fat) meal. In a study by Sanders 
et al128, it was found that FVIIa increased in response to 90 g and 120 g of fat, with a 
peak at 7 hours, but not in response to 15 or 60 g of fat. Kapur and colleagues'32 
demonstrated an increase in FVIIa six hours after a fat rich meal (30 g/m2). Two studies 
by Silveira et al106131, among 31 male post-infarction patients and 24 healthy males, 
showed an increase of FVIIa after six hours, during a fat tolerance test. The absolute 
increase in FVIIa was higher in post-myocardial infarction patients with the RR genotype 
than in patients carrying the Q allele. However, in contrast to our study, the percentual 
increase in FVIIa did not differ between the genotypes106. This discrepancy may be 
explained by different type of subjects; men with myocardial infarction in the study of 
Silveira et al106 and healthy elderly women in our study. However, we think it is more 
likely that Silveira et al106 did not find a difference in percentual response between the 
genotypes because they studied a much smaller number of subjects (31 of whom 8 with 
the RQ genotype). 
One of the mechanisms which may explain an effect of dietary fat on factor VII, is based 
on activation of factor VII by negatively charged surfaces during lipolysis of triglyceride 
rich lipoproteins (TRLP)70. The fact that our data show differences in activation for the R 
and Q allele, independent of the fasting level of FVIIa, suggests a molecular difference 
between the two types of FVIIa in this respect. The results of our study do not clarify how 
the R/Q353 polymorphism could influence the activation of factor VII, but it may be that 
the charge change ensuing from the substitution of the positively charged arginine with a 
neutral glutamine affects the interaction of factor VII with lipid surfaces137. 
In conclusion, the results of this study suggest that FVIIa increases profoundly after a fat 
rich meal in elderly women with the RR genotype of the R/Q353 polymorphism. Since 
this may contribute to the risk of a cardiovascular event or modify its prognosis, a diet 
with a low to moderate fat intake may be recommendable for these subjects. 
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In this thesis a cross-sectional study among 489 elderly men and 669 elderly women (>55 
years) and an intervention study among 91 elderly women (>60 years) are described. 
These studies were designed to investigate (1) the magnitude of the association of FVII:C 
and FVIIt with diet and (2) the response of FVIIa to fat-rich meals with different fatty 
acid composition. For both objectives the modifying effect of the R/Q353 polymorphism 
was taken into account. A complete overview of the main findings of the cross-sectional 
and intervention study described in this thesis is given in Table 8.1 and the most important 
results are mentioned below. 
In the cross-sectional study FVILC and FVIIt were inversely associated with dietary fibre. 
An increase of dietary fibre intake with 10 g per day would lead to a decrease in FVILC 
with 6.4 %PP and in FVIIt with 3.8 %PP. These associations were even higher in subjects 
with the RR genotype, while they were absent in subjects carrying the Q allele. 
Furthermore, in elderly women the association of FVII:C with serum-triglycerides was 
twice as strong in women homozygous for the R allele, compared to women carrying the 
Q allele (Table 8.1). 
The results from the intervention study showed that FVIIa increased after a fat-rich 
breakfast. The absolute response of FVIIa on a fat-rich meal was twice as high in elderly 
women homozygous for the R allele than in those carrying the Q allele. Also the response 
relative to the fasting FVIIa level was 10% higher in women with the RR genotype. There 
was no difference in FVIIa response between fat-rich breakfasts rich in either palmitic 
acid, stearic acid, or linoleic/linolenic acid with a ratio 3:1 or 15:1. Furthermore, we found 
no evidence that serum-triglyceride concentration mediates the effect of dietary fat on 
FVIIa (Table 8.1). 
The methodological aspects of the cross-sectional and intervention study are described in 
the discussion sections of the former chapters. In this chapter, the specific findings will be 
discussed in a broader perspective, with special focus on the biological plausibility. 
Moreover, practical implications and suggestions for future research will be addressed. 
Factor VII and coronary heart disease 
Epidemiologic evidence 
In at least 13 studies the association of factor VII with coronary heart disease has been 
investigated. These studies mainly focused on myocardial infarction as endpoint of 
interest, while in prospective follow up studies total coronary heart disease is taken 
instead. A summary of these studies is given in Table 8.2. 
Two major prospective follow up studies have been performed among male subjects, in 
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Table 8.1. Main findings of the cross-sectional and intervention study described in this 
thesis 
Independent variable Total group* RR* RR/QQ* 
Dietary fibre 
Saturated fat 
Protein 
Triglycerides 
n, 858 RR and 300 RQ/QQ 
FVII:C i 
FVIIt i 
FVII:C T 
FVIIt -
FVII:C i 
FVIIt -
men: 
FVII:C T 
FVIIt T 
women: 
FVII:C TT 
FViit TT 
! FVILC U 
| FVIIt U 
! FVII:C TT 
j FVIIt: T 
! FVII:C 4 
i FVIIt -
| men: 
i FVILC T 
| FVIIt T 
! women: 
j FVILC TT 
i FViit TT 
FVILC --
FVIIt --
FVILC U 
FVIIt i 
FVILC --
FVIIt -
men: 
FVILC T 
FVIIt T 
women: 
FVILC T 
FVIIt T 
Intervention, women, 56 RR and 35 RQ/QQ 
fat-rich breakfast: 
palmitic 
stearic 
linoleic/linolenic 3:1 
linoleic/linolenic 15:1 
fat-free breakfast 
FVIIa TT 
FVIIa TT 
FVIIa TT 
FVIIa TT 
FVIIa i 
FVIIa TTT 
FVIIa TTT 
FVIIa TTT 
FVIIa TTT 
FVIIa U 
FVIIa T 
FVIIa T 
FVIIa T 
FVIIa T 
FVIIa i 
cross-sectional: T = positive association, 1 = inverse association, — = no association, 
more arrows indicate a stronger association 
intervention: T = increase, i = decrease, more arrows indicate a stronger effect 
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Table 8.2. Studies on factor VII and coronary heart disease 
Ref 
2 
6 
3 
46 
47 
48 
138 
139 
140 
141 
142 
143 
144 
Design 
follow up, 6 
years 
follow up, 
19 years 
follow up, 2 
years 
case-control 
case-control 
case-control 
case-control 
case-control 
cross-sec-
tional 
case-control 
case-control 
case-control 
case-control 
Population (age) 
2116 men (49) 
1511 men (40-60) 
335 subjects (55) 
men, 36 case (57) 
7 control (59) 
66 case (62) 
16 control (43) 
15 case (50) 
15 control (32) 
51 case (60) 
31 control (58) 
men, 94 case (40) 
99 control (40) 
2365 subject (54) 
68 case (69) 
37 control (57) 
12 case 
24 case 
32 control (20-80) 
men, 461 case 
Endpoint* 
23 fatal 
CHD 
88 fatal 
CHD 
19 fatal MI 
prior MI 
MI 
CHD 
MI 
MI 
CHD 
CHD 
MI 
MI 
MI 
FVII:C# 
8.4% T 
9.4% t 
15.2% T 
28% T 
22.1% t 
7%T 
(ns) 
-
7%t 
-
-
-
6.2% 4 
FVIIt 
-
21% T 
17% T 
-
-
-
FVIIa 
-
CHD = coronary heart disease, MI = myocardial infarction 
* T = higher in patients compared to healthy control subjects, 1 = lower in patients compared to healthy 
control subjects, — = no difference between groups 
which the relation between factor VII and coronary heart disease was evaluated. Both 
studies showed that FVII:C was almost 10% higher in men who died from coronary heart 
disease compared to those who remained free of coronary heart disease2,6. A difference of 
1 SD in FVII:C was associated with a difference of nearly 50% in the probability of dying 
of coronary heart disease, but with no difference for non-fatal myocardial infarction6. In 
78 
General discussion 
another prospective study, which was relatively small, similar results were obtained3. 
In four case-control studies higher levels of FVII:C46"48'139 or FVIIt48'139 in patients with 
coronary heart disease compared to healthy control subjects were found. However, in other 
studies no differences in FVII:C'38,4014U43, FVIIt47140-'42 or FVIIa139 between persons with 
and without coronary heart disease were observed. The results of one study even showed 
lower FVILC levels in patients with myocardial infarction compared to healthy control 
subjects144. 
The results from the prospective follow up studies show that factor VII is a risk indicator 
for coronary heart disease, while the results from the case-control studies are conflicting. 
This may be explained by the possibility hat the level of factor VII is changed as a 
consequence of a coronary event. In that case, the case-control design may not be suitable 
for studying factor VII. From all these studies it is, however, not clear whether factor VII 
is indeed causally linked to coronary heart disease. 
Biological explanations 
The question remains whether it is FVIIt or FVIIa which is important for coronary heart 
disease. Total factor VII is present in excess and one may think that a small increase in 
the total amount would probably not affect the thrombotic tendency. The amount of FVIIa 
in the circulation, however, is limited and it is therefore conceivable that when tissue 
factor is present, even a small increase in FVIIa may lead to an extreme formation of 
thrombin. This would lead to an imbalance in the haemostatic process and thereby to 
thrombosis. This is supported by the observation that active site-inhibited FVIIa competes 
with normal FVIIa for tissue factor and is a useful competitive inhibitor of thrombus 
formation initiated by acute arterial injury145. 
Coronary thrombosis occurs almost exclusively in atherosclerotic arteries146 as a result of 
plaque rupture147148. FVIIa becomes important at the moment of plaque rupture, when 
large amounts of tissue factor present in the plaque are released149150. The amount of 
activated factor VII in the circulation at that time may determine the size of the resulting 
blood clot and therefore the outcome of the event. This may also explain why factor VII is 
more clearly associated with fatal than with non-fatal coronary heart disease. Possibly, 
fatality is a consequence of more extensive clot formation in larger coronary vessels. 
Furthermore, the chance of a plaque rupture may be larger when more atherosclerosis is 
present and when the plaque is rich in cholesterol crystals151. In elderly, the prevalence of 
atherosclerosis is high and the type of plaque may be more susceptible to rupture 
compared with younger individuals. Occurrence of thrombosis on top of the existing 
atherosclerosis will probably increase the risk of a coronary event in elderly people. As 
factor VII has a key position in the formation of a thrombus at the moment of plaque 
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rupture, it may have more public health importance in elderly people than in young or 
middle-aged people. 
Although there seems to be evidence that FVIIa is important in coronary heart disease, we 
should not forget that FVIIa is but one factor in the whole haemostatic system. The 
thrombotic-thrombolytic equilibrium at the time of plaque rupture plays a decisive role in 
the thrombotic response and hence in the outcome of the event152. At this time we do not 
know exactly how this equilibrium is regulated and no method is available to measure the 
state of this balance. Therefore, as a surrogate, measurements of factors which we think 
affect this balance are used in studies to investigate the onset and development of coronary 
heart disease. Examples of such factors associated with coronary heart disease in 
prospective follow up studies are fibrinogen, factor VIII and plasminogen activator 
inhibitor3'4153. Future research including measurement of FVIIa in stead of FVILC, may 
contribute to elucidating the thrombotic processes taking place during a cardiovascular 
event. 
Factor VII and dietary fat 
It is well known that factor VII is influenced by dietary fat120. A biological explanation for 
this relationship may be founded on the association between serum-triglycerides and factor 
VII. Several mechanisms are suggested which describe the causal pathway from intake of 
dietary fat to an increase in factor VII. These possible mechanisms are extensively 
described in Chapter 2 and are summarized in Figure 8.1. 
There are, however, some weaknesses in these hypothesized mechanisms. Mechanism A 
and B both explain the association of FVIIt with dietary fat27,67"69. As evidence for 
mechanism A indeed binding between FVIIt and triglyceride rich lipoproteins (TRLP) in 
vitro was found, but it is not clear whether this actually reduces the clearance in vivo. The 
evidence for mechanism B is quite scarce. Stimulation of the hepatic production of factor 
VII by fragment 1+2 has been shown in rabbits69, but it is not known whether this occurs 
in humans as well. Mechanism C is most extensively investigated. It explains the 
postprandial activation of factor VII after fat consumption. In a study among patients with 
lipoprotein lipase deficiency no activation of factor VII after a fat-rich meal was seen73. 
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Figure 8.1. Possible mechanisms explaining the association of dietary fat with factor VII 
TRLP = triglyceride rich lipoproteins 
A: TRLP - FVIIt complex >- FVIIt clearance { 
B: hypertriglyceridaemia >-FVTIa| • fragment 1+2 * 
FVII liver synthesis J 
C: lipolysis of TRLP • FVna | 
This means that factor VII is activated during lipolysis of TRLP. As the half life time of 
chylomicron remnants is longest after a saturated fat meal108, the postprandial increase in 
FVIIa is expected to be larger after saturated fat compared to unsaturated fat. The results 
of our study do not confirm this, since the response of FVIIa was similar for meals rich in 
unsaturated and saturated fat. Furthermore, when 1 g of fish oil a day is consumed, the 
amount of TRLP decreases and the length and level of the postprandial hyperlipidaemia 
are lower109. There are no studies which investigated the postprandial response of FVIIa 
after a meal with fish. However, in studies which evaluated FVII:C in relation to a long-
term fish diet, no change in FVILC was observed81'90. In two of those studies which did 
show an effect, an increase in FVILC after the fish diet rather than a decrease was 
found81,90. This suggests that the differences in postprandial lipaemia between different fat 
types may be too small to be reflected in the activation of factor VII. Also the lack of 
association between postprandial FVIIa and serum-triglycerides as observed in our 
intervention study may indicate that it is not the amount of TRLP which is involved in the 
process, but rather the way the TRLP are metablised. These discrepancies between what 
would be expected according to the proposed mechanisms and what is observed in 
experimental studies may rely on the shortage of knowledge of the exact metabolism of 
fatty acids and the involvement of other factors in this process. 
Another aspect of mechanism C is the involvement of other coagulation factors. First it 
was thought that the negatively charged surfaces of the TRLP, existing during lipolysis, 
would activate factor XII and thereby factor VII70. Lately it became evident that factor IX 
and not factor XII plays a role in this process. This was based on the observation that 
patients who were deficient of factor XII showed a normal postprandial increase in FVIIa, 
81 
Chapter 8 
while patients deficient in factor IX did not'30131. This may be explained by the inhibition 
of FVIIa by tissue factor pathway inhibitor (TFPI). FVIIa in complex with factor X is 
quickly inhibited by TFPI, while re-activation of factor VII through factor IX can not 
occur, since factor IX is not present. Therefore, no postprandial increase in FVIIa will be 
seen. 
In conclusion mechanism A and B could explain the increase in fasting FVILC seen after 
a high-fat diet. If these mechanisms are true, one would only expect an increase in fasting 
FVIIt, and not in fasting FVIIa after a long-term high-fat diet. Future research should 
clarify whether this indeed is true. Mechanism C could explain the postprandial increase 
of FVIIa, although the exact pathway for the activation of factor VII by TRLP is still 
obscure. 
The question remains whether an increase in FVIIa after a fat-rich meal indeed leads to an 
increased formation of thrombin, and thereby to a higher risk of a thrombotic event. Kapur 
et al132 were not able to show a postprandial increase in fragment 1+2, a marker of 
thrombin generation, concomitant with an increase in FVIIa after a fat-rich meal. 
However, in a non-disease situation there will be no release of tissue factor, nor triggering 
of the coagulation cascade and consequently no increase in fragment 1+2. It would be 
interesting to know whether an increase in FVIIa leads to an increase in clot formation at 
the instant tissue factor is released, for example during plaque rupture. For now, however, 
there is no reliable method available to determine the potential blood clot formation at a 
certain FVIIa level. 
Factor VII and genetics 
The gene coding for factor VII shows strong sequence and organizational homology with 
the other vitamin K-dependent clotting factors and is located close to the gene encoding 
coagulation factor X on chromosome 13'54. Figure 8.2 shows the gene coding for factor 
VII, which has eight introns and nine exons. 
Three polymorphisms of the factor VII locus have been associated with plasma levels of 
FVILC, FVIIt and FVIIa23121155156. About 30% of the variation in plasma FVILC can be 
explained by these polymorphisms of the factor VII locus121. In the promoter region of the 
gene the -3231ns 10 polymorphism is a consequence of an insertion of the sequence 
CCTATATCCT157. It has two alleles, P0 and P10, of which the latter is associated with 
lower levels of factor VII'21. In intron 7 the HVR4 polymorphism consists of a variable 
number of tandem repeats of 37 bp158. The alleles of the HVR4 polymorphism contain 
between 4 and 8 repeats and are named H5 to H8. Since the HVR4 polymorphism is 
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situated in an intron, it is supposed to be a marker of another polymorphism which 
influences the level of factor VII. The R/Q353 polymorphism is the most extensively 
studied polymorphism of the factor VII gene at this moment. It is located in exon 8 and is 
Figure 8.2. The factor VII gene and the three known polymorphisms 
[_] = exon (coding part), = intron (non-coding parts) HVR4 
lb 
-323InslO 
Y 
R/Q353 
caused by a substitution of guanine by adenine in the codon for amino acid 353. This 
leads to a replacement of arginine (R) by glutamine (Q) in the factor VII protein. The 
R/Q353 and the -3231ns polymorphism are closely linked, and the Q and the P10 allele are 
both associated with lower levels of FVIIa, FVIIt and FVILC156. 
As the position of the -3231ns 10 polymorphism is upstream from the start of translation of 
the gene, it seems the best candidate to have a functional effect on the level of factor VII. 
Indeed Humphries et al'07 showed a stronger association of FVILC and FVIIt with this 
polymorphism compared to the R/Q353 polymorphism. In contrast Heywood et al'59 
showed a greater predictive value for FVILC levels of the R/Q353 polymorphism than of 
the -3231ns 10 polymorphism. This suggests that both polymorphisms may be linked to one 
or more as yet unidentified polymorphisms, which may have different functional effects on 
either FVIIa or FVIIt. It seems conceivable that the -3231ns 10 polymorphism (located in 
the promoter region) would only affect the synthesis of factor VII, while the R/Q353 
polymorphism (located in an exon) would affect the activity of factor VII. Differences in 
susceptibility to the level of FVIIa and FVIIt in the measurement of FVILC between the 
studies of Heywood et al159 and Humphries et al107, may therefore also explain their 
contradicting results. 
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Lane et al studied the association between the R/Q353 polymorphism and the presence of 
myocardial infarction144. There was no difference in the distribution of the RR or RQ/QQ 
genotypes between the case and control subjects. This may be explained by the fact that 
this study included males only. In our studies we have shown that there is a remarkable 
difference between men and women concerning the effects of the R/Q353 polymorphism 
on the associations of factor VII with serum-triglycerides. It may be that the R/Q353 
polymorphism (or the functional polymorphism responsible for the differences in FVIIa 
levels) has a larger effect in women than in men. The results of Lane et al'44 may also 
reflect the view that factor VII is more strongly related to fatal coronary heart disease. 
Their case-control study did not include fatal events, which may have caused an 
underestimation of the presence of the R-allele in the cases. 
In our cross-sectional study it was observed that the R/Q353 polymorphism affects the 
association of FVILC and FVIIt with dietary factors and serum-triglycerides. In our 
intervention trial it was shown that also the response of FVIIa to a fat-rich meal depends 
on the genotype for the R/Q353 polymorphism. The charge change ensuing from the 
substitution of the positively charged arginine with a neutral glutamine may affect the 
interaction of factor VII with lipid surfaces'37, which could explain our observations. This 
does not account for the differences between genotype groups in the association of FVII:C 
and FVIIt with dietary fibre and protein. Moreover, if the R/Q353 polymorphism is not a 
functional one, the explanation may be completely different. 
In conclusion circulating levels of FVIIa may be important for the outcome of a coronary 
event. These levels are influenced by diet, blood lipids and by genetic polymorphisms 
(Figure 8.3). Besides a direct influence of genetic polymorphisms on FVIIa, they also 
affect the level indirectly through a modifying effect on the relation of FVIIa with diet and 
blood lipids. It is conceivable that an individual with a specific genetic variant may have 
high fasting levels of FVIIa compared to individuals with another variant. Subsequently, 
consumption of a high-fat meal by this susceptible subject may result in a dramatic 
increase in FVIIa. These extremely increased levels are caused by a synergy between the 
intake of dietary fat and the genetic variant. This synergy between diet and genetic factors, 
which will lead to profoundly elevated FVIIa levels after a high-fat dinner, may be one of 
the explanations of the small peak in thrombotic events in the evening'60161. 
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Practical implications 
During the last years nutrition education has been focused on a reduction of total fat 
intake and an exchange of saturated fat for unsaturated fat. These recommendations 
intended to achieve a reduction of LDL cholesterol level and thereby a reduction in the 
incidence of cardiovascular disease. Lately a debate has started on the value of lowering 
the total fat content in the diet162. A replacement of fat by carbohydrates in the diet will 
indeed lead to a decrease in LDL cholesterol, but also to a decrease in HDL cholesterol163. 
Figure 8.3. Interrelations of FVIIa with genetic factors, diet, triglyceride rich lipoproteins 
(TRLP), and coronary heart disease (CHD) 
GENETIC POLYMORPHISMS 
DIET *• BLOOD LIPIDS 
CHD 
This means that the lipoprotein profile (ratio LDL/HDL) will not improve and a low-fat 
diet will not lead to a decreased risk of cardiovascular disease. Therefore, some argue that 
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recommendations should only address the fat composition and not the total amount of fat. 
However, as we have shown in this thesis, total fat intake does affect the level of FVIIa. 
Since the risk of coronary events may be higher at peak levels of FVIIa, reduction of total 
fat intake may indeed be worthwhile. In the discussion on the efficacy of low-fat diets in 
prevention of cardiovascular disease, the reducing effect of low total fat intake on FVIIa 
should be included. 
The results from our cross-sectional study on dietary fibre need to be confirmed in 
intervention studies. If indeed an increase in the intake of dietary fibre results in a 
decrease of FVIIa, this would be a valuable scientific basis for the recommendation to 
increase the consumption of dietary fibre. Furthermore, if confirmed by others, our results 
indicate that a change in the diet of elderly people may lead to a improvement of their risk 
profile for thrombotic events. 
From the studies described in this thesis it seems evident that the R/Q353 polymorphism 
modifies the response of factor VII to a change in the diet. Recommendations for 
screening of the population on polymorphisms of the factor VII gene seem rather 
premature. There are several aspects to consider before we can decide if screening of the 
population for a factor VII polymorphism is useful. First we should know whether FVIIa 
is indeed a risk factor for coronary heart disease. Secondly, it must be clear which 
polymorphism(s) have a functional effect on the level of FVIIa. Finally, we should know 
if and how the polymorphism in the factor VII gene interacts with other polymorphisms 
important for coronary heart disease. However, it is conceivable that in the distant future 
people at high risk for cardiovascular disease will be screened for their susceptibility to a 
certain dietary change. A polymorphism in the factor VII gene may be one of the 
candidates for such preventive susceptibility screening. 
Factor VII and future research 
In this thesis only the R/Q353 polymorphism of the factor VII gene is studied. Several 
other polymorphisms which are associated with the factor VII level have been identified, 
and it is likely that in the future more will be discovered. It is, however, not clear which 
polymorphism is in fact responsible for the difference in FVIIa levels between people, i.e. 
which is the functional polymorphism. Of course a certain haplotype could also be 
especially important for the level of FVIIa. Molecular and biochemical research is needed 
to clarify this and to clarify the mechanism by which the genetic factors affect the 
association of factor VII with diet. 
Prospective studies on factor VII and coronary heart disease have so far been focused on 
FVII:C. Although FVIIa seems more relevant than FVII:C in this case, it has not been 
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included in prospective studies. Epidemiological research is needed to find out whether 
FVIIa is really implicated in the causal pathway of coronary heart disease, or whether it is 
merely a risk indicator. An answer to this question may be easy to find in a case-control 
setting using the functional polymorphism that determines the level of FVIIa. Including a 
genetic factor as an independent variable eliminates bias caused by a change in FVIIa 
level as a result of the coronary event. In the case-control study fatal cases of coronary 
heart disease events should be taken as an endpoint and the polymorphism should be 
determined. If possible blood samples can be obtained for measurement of FVIIa. If the 
FVIIa levels correlate well with the polymorphism, results of the study should be able to 
show whether FVIIa is indeed a risk factor. 
Many intervention studies on factor VII and dietary fat have so far been performed, but 
not many have included measurement of FVIIa. The fluctuation of FVIIa during a day 
with habitual meals could be studied, to identify at which time a peak level of FVIIa 
occurs in normal life. At the same time it can be studied whether lower amounts of fat as 
compared to high-fat meals also increase postprandial FVIIa, i.e. if there is a dose-
response relation. In order to further clarify the mechanism behind the relation of factor 
VII and dietary fat it may be interesting to look at polymorphisms which affect lipoprotein 
lipase activity or the lipoprotein metabolism. An example of such a polymorphism could 
be the different Apo E variants. Furthermore intervention studies on FVIIa and a long-term 
diet rich in dietary fibre are essential, as FVIIa measurement was not included in studies 
on this subject before. Not only different amounts of dietary fibre but also different types 
of fibre, soluble or non-soluble, should be evaluated. 
87 
REFERENCES 
1. Meade TW, Brozovic M, Chakrabarti RR, Haines AP, Imeson JD, Mellows S, Miller GJ, North WRS, 
Stirling Y, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the 
Northwick Park Heart Study. The Lancet 1986;6:533-537. 
2. Heinrich J, Balleisen L, Schulte H, Assmann G, Loo J van de. Fibrinogen and factor VII in the 
prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 
1994;14:54-59. 
3. Cortellaro M, Boschetti C, Cofrancesco E, Zanussi C, Catalano M, de Gaetano G, Gabrielli L, 
Lombardi B, Specchia G, Tavazzi L, Tremoli E, della Volpe A, Polli E. The PLAT study: hemostatic 
function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. 
Arterioscler Thromb 1992;12:1063-1070. 
4. Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC. Fibrin-
ogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The 
Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation 1991;83:836-844. 
5. Furie B, Furie BC. Molecular and cellular biology of blood coagulation. New Engl J Med 1992;326: 
800-806. 
6. Ruddock V, Meade TW. Factor VII activity and ischaemic heart disease: fatal and non-fatal events. Q J 
Med 1994;87:403-406. 
7. Dodds WJ. Clinical biochemistry of domestic animals. Academic Press, 1989. p. 274-313. 
8. Radcliffe R, Nemerson Y. Activation and control of factor VII by activated factor X and thrombin. 
Isolation and characterization of a single chain form of factor VII. J Biol Chem 1975;250:388-395. 
9. Radcliffe R, Bagdasarian A, Colman RW, Nemerson Y. Activation of bovine factor VII by hageman 
factor fragments. Blood 1977;50:611-617. 
10. Seligsohn U, 0sterud B, Brown SF, Griffin M, Rapaport SI. Activation of human factor VII in plasma 
and in purified systems. J Clin Invest 1979,64:1056-1065. 
11. Balleisen L, Bailey J, Epping PH, Schulte H, Loo J van de. Epidemiological study on factor VII, factor 
VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-
weight, smoking, alcohol, pill-using and menopause. Thromb Haemost 1985;54:475-479. 
12. Folsom AR, Conlan MG, Davis CE, Wu KK. Relations between hemostasis variables and cardiovascu-
lar risk factors in middle-aged adults. Ann Epidemiol 1992;4:481-494. 
13. Scarabin PY, Vissac AM, Kirzin JM, Bourgeat P, Amiral J, Agher R, Guize L. Population correlates of 
coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated 
factor VII. Arterioscler Thromb Vase Biol 1996;16:1170-1176. 
14. Scarabin PY, Bonithon-Kopp C, Bara L, Malmejac A, Guize L, Samama M. Factor VII activation and 
menopausal status. Thromb Res 1990;57:227-234. 
15. Balleisen L, Assmann G, Bailey J, Epping PH, Schulte H, Loo J van de. Epidemiological study on 
factor VII, factor VIII and fibrinogen in an industrial population: II. Baseline data on the relation to 
blood pressure, blood glucose, uric acid, and lipid fractions. Thromb Haemost 1985;54:721-723. 
16. Donders SHJ, Lustermans FAT, Wersch JWJ van. Coagulation factors and lipid composition of the 
blood in treated and untreated hypertensive patients. Scand J Clin Lab Invest 1993;53:179-186. 
17. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting 
factors and the risk of ischaemic heart disease. The Lancet 1987;ii:986-988. 
89 
References 
18. Bak AAA, van Vliet HHDM, Grobbee DE. Coffee, caffeine and hemostasis: results from two randomi-
zed studies. Atherosclerosis 1990;83:249-255. 
19. Miller GJ, Cruickshank JK, Ellis LJ, Thompson RL, Wilkes HC, Stirling Y, Mitropoulos KA, Allison 
JV, Fox TE, Walker AO. Fat consumption and factor VII coagulant activity in middle-aged men. An 
association between a dietary and thrombogenic coronary risk factor. Atherosclerosis 1989;78:19-24. 
20. Marckmann P, Sandstrom B, Jespersen J. Effects of total fat content and fatty acid composition in diet 
on factor VII coagulant activity and blood lipids. Atherosclerosis 1990;80:227-233. 
21. Kario K, Matsuo T, Kario T, Kobayashi H. Sex-related differences in the relationship between plasma 
factor VII levels and serum lipids, lipoproteins and apolipoproteins. Thromb Res 1991;64:69-73. 
22. Hoffman CJ, Lawson WE, Miller RH, Hultin MB. Correlation of vitamin K-dependent clotting factors 
with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 1994;14:1737-1740. 
23. Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism 
associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 
1991;11:540-546. 
24. Pekkanen J, Mutanen M, Rasanen L, Rauramaa R, Nissinen A. Association of factor VIIc activity with 
dietary fat and blood lipids among elderly men - The Finnish cohorts of The Seven Countries Study. 
Nutr Metab Cardiovasc Dis 1995;5:149-154. 
25. Brace LD, Gittler-Buffa C, Miller GJ, Cole TG, Schmeisser D, Prewitt TE, Bowen PE. Factor VII 
coagulant activity and cholesterol changes in premenopausal women consuming a long-term cholesterol-
lowering diet. Arterioscler Thromb 1994;14: 1284-1289. 
26. Tholstrup T, Marckmann P, Jespersen J, Sandstrom B. Fat high in stearic acid favorably affects blood 
lipids and factor VII coagulant activity in comparison with fats high in palmitic or high in myristic and 
lauric acids. Am J Clin Nutr 1994;59:371-7. 
27. Bladbjerg EM, Tholstrup T, Marckmann P, Sandstrom B, Jespersen J. Dietary changes in fasting levels 
of factor VII coagulant activity (FVII:C) are accompanied by changes in factor VII protein and other 
vitamin K-dependent proteins. Thromb Haemost 1995;73:239-242. 
28. Miller GJ, Martin JC, Mitropoulos KA, Reeves BEA, Thompson RL, Meade TW, Cooper JA, Cruick-
shank JK. Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat 
composition. Atherosclerosis 1991;86:163-171. 
29. Marckmann P, Sandstrom, Jespersen J. Dietary effects on circadian fluctuation in human blood 
coagulation factor VII and fibrinolysis. Atherosclerosis 1993;102:225-234. 
30. Bladbjerg EM, Marckmann P, Sandstrom B, Jespersen J. Non-fasting factor VII coagulant activity 
(FVJJ:C) increased by high-fat diet. Thromb Haemost 1994;71:755-758. 
31. Silveira A, Karpe F, Blomback M, Steiner G, Walldius G, Hamsten A. Activation of coagulation factor 
VII during alimentary lipemia. Arterioscler Thromb 1994;14:60-69. 
32. Salomaa V, Rasi V, Pekkanen J, Jauhiainen M, Vahtera E, Pietinen P, Korhonen H, Kuulasmaa K, 
Ehnholm C. The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and 
hemostatic activity. Atherosclerosis 1993,103:1-11. 
33. Mutanen M, Krusius T, Rasanen L, Freese R, Vahtera E, Viikari JSA. Habitual diet, platelet function, 
fibrinogen and factor VII coagulant activity in young Finns. J Intern Med 1995;237:577-583. 
34. Rankinen T, Rauramaa R, Vaisanen S, Penttila JM, Uusitupa M. Relation of habitual diet and cardiores-
piratory fitness to blood coagulation and fibrinolytic factors. Thromb Haemost 1994;71:180-183. 
35. Simpson HCR, Mann JI, Chakrabarti R. Effect of high-fibre diet on haemostatic variables in diabetes. 
90 
Br Med J 1982;284:1608. 
36. Miller GJ, Martin JC, Webster J, Wilkes H, Miller NE, Wilkinson WH, Meade TW. Association 
between dietary fat intake and plasma factor VII coagulant activity - A predictor of cardiovascular 
mortality. Atherosclerosis 1986;60:269-277. 
37. Kario K, Matsuo T, Kario T, Kobayashi H. Sex-related differences in the relationship between plasma 
factor VII levels and serum lipids, lipoproteins and apolipoproteins. Thromb Res 1991;64:69-73. 
38. Tervahauta M, Pekkanen J, Kivinen P, Stengard J, Jauhiainen M, Ehnholm C, Nissinen A. Prevalence 
of coronary heart disease and associated risk factors among elderly Finnish men in the Seven Countries 
Study. Atherosclerosis 1993;104:47-59. 
39. Elwood PC, Beswick AD, O'Brien JR, Yarnell JWG, Layzell JC, Limb ES. Inter-relationships between 
haemostatic tests and the effects of some dietary determinants in the Caerphilly cohort of older men. 
Blood Coagulat Fibrinol 1993;4:529-536. 
40. Donders SHJ, Lustermans FAT, Wersch JWJ van. Glycometabolic control, lipids, and coagulation 
parameters in patients with non-insulin-dependent diabetes mellitus. Int J Clin Lab Res 1993;23:155-
159. 
41. Hoffman CJ, Miller RH, Hultin MB. Correlation of factor VII activity and antigen with cholesterol and 
triglycerides in healthy young adults. Arterioscler Thromb 1992;12:267-270. 
42. Howard PR, Bovill EG, Pike J, Church WR, Tracy RP. Factor VII antigen levels in a healthy blood 
donor population. Thromb Haemost 1994;72:21-27. 
43. Green D, Chamberlain MA, Ruth KJ, Folsom AR, Liu K. Factor VII, cholesterol and triglycerides. The 
CARDIA study. Arterioscler Thromb Vase Biol 1997;17:51-55. 
44. Miller GJ, Stirling Y, Esnouf MP, Heinrich J, van de Loo J, Kienast J, Wu KK, Morrissey JH, Meade 
TW, Martin JC, Imeson JD, Cooper JA, Finch A. Factor VH-deficient substrate plasmas depleted of 
protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. 
Thromb and Haemost 1994;71:38-48. 
45. Folsom AR, Wu KK, Shahar E, Davis CE. Association of hemostatic variables with prevalent 
cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arterioscler Thromb 1993; 13: 
1829-1836. 
46. Broadhurst P, Kelleher C, Hughes L, Imeson JD, Raftery EB. Fibrinogen, factor VII clotting activity 
and coronary artery disease severity. Atherosclerosis 1990;85:169-173. 
47. Carvalho de Sousa J, Azevedo J, Soria C. Factor VII hyperactivation in acute myocardial thrombosis. A 
relation to the coagulation activation. Thromb Res 1988;51:165-173. 
48. Hoffman CJ, Miller RH, Lawson WE, Hultin MB. Elevation of factor VII activity and mass in young 
adults at risk of ischemic heart disease. J Am Coll Cardiol 1989;941-946. 
49. Hoffman CJ, Burns P, Lawson WE, Katz JP, Miller RH, Hultin MB. Plasma fibrinogen level is not 
elevated in young adults from families with premature ischemic heart disease. Arterioscler Thromb 
1993;13:800-803. 
50. Hoffman C, Shah A, Sodums M, Hultin MB. Factor VII activity state in coronary artery disease. J Lab 
Clin Med 1988;111:475-481. 
51. Suzuki T, Yamauchi K, Matsushita T, Furumichi T, Furui H, Tsuzuki J, Saito H. Elevation of factor 
VII activity and mass in coronary artery disease of varying severity. Clin Cardiol 1991;14:731-736. 
52. Wu KK, Folsom AR, Heiss G, Davis CE, Conlan MG, Barnes R. Association of coagulation factors 
and inhibitors with carotid artery atherosclerosis. Early results of the atherosclerosis risk in communities 
(ARIC) study. Ann Epidemiol 1992;4:471-480. 
91 
References 
53. Sosef MN, Bosch JG, Oostayen J van, Visser T, Reiber JHC, Rosendaal FR. Relation of plasma 
coagulation factor VII and fibrinogen to carotid artery intima-media thickness. Thromb Haemost 
1994;72:250-254. 
54. Heinrich J, Wahrburg U, Marting H, Assmann G. The effect of diets, rich in mono- or polyunsaturated 
fatty acids, on lipid metabolism and haemostasis. Fibrinolysis 1990;4:76-78. 
55. Bruckert E, Carvalho de Sousa J, Giral P, Soria C, Chapman M, Caen J, de Gennes JL. Interrela-
tionships of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholes-
terolemia. Atherosclerosis 1989;75:129-134. 
56. Carvalho de Sousa J, Bruckert E, Giral P, Soria C, Chapman J, Truffert J, Dairou F, de Gennes JL, 
Caen JP. Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible 
mechanism of factor VII hyperactivity. Haemostasis 1989;19: 125-130. 
57. Lane A, Cruickshank JK, Mitchell J, Henderson A, Humphries S, Green F. Genetic and environmental 
determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease. 
Atherosclerosis 1992;94:43-50. 
58. Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and antigen 
levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceri-
de concentration. Arterioscler Thromb 1994;14:193-198. 
59. Fuller JH, Keen H, Jarret RJ, Omer T, Meade TW, Chakrabarti R, North WRS, Stirling Y. Haemostatic 
variables associated with diabetes and its complications. Br Med J 1979;2:964-966. 
60. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in 
plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 
1993:81:734-744. 
61. Kitchen S, Malia RG, Preston FE. A comparison of methods for the measurement of activated factor 
VII. Thromb Haemost 1992;68:301-305. 
62. Poggio M, Tripodi A, Mariani G, Mannucci PM. Factor VII clotting assay: influence of different 
thromboplastins and factor VH-deficient plasmas. Thromb Haemost 1991;65:160-164. 
63. Deijk WA, Dam-Mieras MCE van, Muller D, Hemker HC. Evaluation of a coagulation assay 
determining the activity state of factor VII in plasma. Haemostasis 1983;13:192-197. 
64. Hemker HC, Muller AD, Gonggrijp R. The estimation of activated human blood coagulation factor VII. 
J Molecular Med 1976;1:127-134. 
65. Messmore HL, Koza M, Hoppensteadt D, Blakemore C, Walenga J. Results of factor VII assays in 
adults with vascular disease are dependent upon several variables. Thromb Haemost 1991;65:909. 
66. 0sterud B. How to measure factor VII and factor VII activation. Haemostasis 1983;13:161-168. 
67. Carvalho de Sousa J, Soria C, Ayrault-Jarrier M, Pastier D, Bruckert E, Amiral J, Bereziat G, Caen JP. 
Association between coagulation factors VII and X with triglyceride rich lipoproteins. J Clin Pathol 
1988;41:940-944. 
68. Miller GJ. Hyperlipidaemia and hypercoagulability. Prog Lipid Res 1993;32:61-69. 
69. Mitropoulos KA, Esnouf MP. The prothrombin activation peptide regulates synthesis of the vitamin K-
dependent proteins in the rabbit. Thromb Res 1990;57:541-549. 
70. Mitropoulos KA, Miller GJ, Reeves BEA, Wilkes HC, Cruickshank JK. Factor VII coagulant activity is 
strongly associated with the plasma concentration of large lipoproteins particles in middle aged men. 
Atherosclerosis 1989;76:203-208. 
71. Mitropoulos KA, Martin JC, Reeves BEA, Esnouf MP. The activation of the contact phase of 
92 
coagulation by physiologic surfaces in plasma: the effect of large negatively charged liposomal vesicles. 
Blood 1989;73:1525-1533. 
72. Mitropoulos KA, Reeves BEA, Miller GJ. The activation of factor VII in citrated plasma by charged 
long-chain saturated fatty acids at the interface of large triglyceride-rich lipoproteins. Blood Coagul 
Fibrinol 1993;4:943-951. 
73. Mitropoulos KA, Miller GJ, Watts GF, Durrington PN. Lipolysis of triglyceride-rich lipoproteins 
activates coagulant factor VII: a study in familial lipoprotein-lipase deficiency. Atherosclerosis 
1992;95:119-25. 
74. Marckmann P, Sandstrom B, Jespersen J. Fasting blood coagulation and fibrinolysis of young adults 
unchanged by reduction in dietary fat content. Arterioscler Thromb 1992;12:201-205. 
75. Marckmann P, Sandstrom B, Jespersen J. Low-fat, high-fibre diet favorably affects several independent 
risk markers of ischemic heart disease: observations on blood lipids, coagulation, and fibrinolysis from 
a trial of middle-aged Danes. Am J Clin Nutr 1994;59:935-939. 
76. Marckmann P, Sandstrom B, Jespersen J. Favorable long-term effect of a low-fat/high-fibre diet on 
human blood coagulation and fibrinolysis. Arterioscler Thromb 1993;13:505-511. 
77. Miller GJ, Stirling Y, Howarth DJ, Cooper JC, Green FR, Lane A, Humphries SE. Dietary fat intake 
and plasma factor VII antigen concentration. Thromb Haemost 1995;73:893. 
78. Foley M, Ball M, Chisholm A, Duncan A, Spears G, Mann J. Should mono- or poly-unsaturated fats 
replace saturated fat in the diet? Eur J Clin Nutr 1992;46:429-436. 
79. Tholstrup T, Marckmann P, Jespersen J, Vessby B, Jart A, Sandstrom B. Effect on blood lipids, 
coagulation, and fibrinolysis of a fat high in myristic acid and a fat high in palmitic acid. Am J Clin 
Nutr 1994;60:919-925. 
80. Rankinen T, Rauramaa R, Vaisanen S, Halonen P, Penttila IM. Blood coagulation and fibrinolytic 
factors are unchanged by aerobic exercise or fat modified diet. Fibrinolysis 1994;8:48-53. 
81. Hendra TJ, Britton ME, Roper DR. Effects of fish oil supplements in NIDDM subjects. Diabetes Care 
1990;13:821-829. 
82. Shahar E, Folsom AR, Wu KK, Dennis BH, Shimakawa T, Conlan MG, Davis CE, Williams OD. 
Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. 
Arterioscler Thromb 1993;13:1205-1212. 
83. Schmidt EB, Lervang HH, Varming K, Madsen P, Dyerberg J. Long-term supplementation with n-3 
fatty acids. I: Effect on blood lipids, haemostasis and blood pressure. Scand J Clin Lab Invest 
1992;53:221-228. 
84. Marckmann P, Jespersen J, Leth T, Sandstrom B. Effect of fish diet versus meat diet on blood lipids, 
coagulation and fibrinolysis in healthy young men. J Int Med 1991;229:317-323. 
85. Lervang HH, Schmidt EB, M0ller J, Svaneborg N, Varming K, Madsen PH, Dyerberg J. The effect of 
low-dose supplementation with n-3 polyunsaturated fatty acids on some risk markers of coronary heart 
disease. Scand J Clin Lab Invest 1993;53:417-423. 
86. Muller AD, van Houwelingen AC, van Dam-Mieras MCE, Bas BM, Hornstra G. Effect of a moderate 
fish intake on haemostatic parameters in healthy males. Thromb Haemost 1989;61:468-473. 
87. Brown AJ, Roberts DCK. Fish and fish oil intake: effect on hematological variables related to 
cardiovascular disease. Thromb Res 1991;64:169-178. 
88. Berg-Schmidt E, Varming K, Ernst E, Madsen P, Dyerberg J. Dose-response studies on the effect of 
n-3 polyunsaturated fatty acids on lipids and haemostasis. Thromb Haemost 1990;63:1-5. 
89. Nord0y A, Hatcher L. Goodnight S, Fitzgerals GA, Connor WE. Effects of dietary fat content, saturated 
93 
References 
fatty acids, and fish oil on eicosanoid production and hemostatic parameters in normal men. J Lab Clin 
Med 1994;123:914-920. 
90. Hornstra G. Effect of fish oil feeding on arterial thrombosis, platelet function and blood coagulation. In: 
Dietary Fats, Prostanoids and arterial thrombosis. Martinus Nijhoff Publishers, The Hague 1982; pp 
106-137. 
91. Moor E, Hamsten A, Karpe F, Bavenholm P, Blomback M, Silveira A. Relationship of tissue factor 
pathway inhibitor activity to plasma lipoproteins and myocardial infarction at a young age. Thromb 
Haemost 1994;71:707-712. 
92. Mitropoulos KA, Miller GJ, Martin JC, Reeves BEA, Cooper J. Dietary fat induces changes in factor 
VII coagulant activity through effects on plasma free stearic acid concentration. Arterioscler Thromb 
1994;14:214-222. 
93. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and 
long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. The Lancet 
1993;342:1076-1079. 
94. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma 
fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991;91:191-205. 
95. Wright D, Poller L, Thomson JM, Gowland E, Burrows GE. The inter-relationship of factor VII and its 
activity state with plasma lipids in healthy male adults. Br J Haematol 1993;85:348-351. 
96. Negri M, Arigliano PL, Talamini G, Carlini S, Manzato F, Bonadonna G. Levels of plasma factor VII 
and factor VII activated forms as a function of plasma triglyceride levels. Atherosclerosis 1993;99:55-
61. 
97. Marckmann P, Sandstrom B, Jespersen J. The variability of and associations between measures of 
blood coagulation, fibrinolysis and blood lipids. Atherosclerosis 1992;96:235-244. 
98. Manolio TE, Ettinger WH, Tracy RP, Kuller LH, Borhani NO, Lunch JC, Fried LP. Epidemiology of 
low cholesterol levels in older adults. Circulation 1993;87:728-737. 
99. Yang XC, Jing TY, Resnick LM, Phillips GB. Relation of hemostatic risk factors to other risk factors 
for coronary heart disease and to sex hormones in men. Arterioscler Thromb 1993;13:467-471. 
100. Fredricksson DS, Levy RI, Lees RS. Fat transport in lipoproteins. An integrated approach to mecha-
nisms and disorders. N Engl J Med 1967;276:94-103. 
101. Carvalho de Sousa J, Bruckert E, Giral P, Soria C, Truffert J, Mirshahi MC, de Gennes JL, Caen JP. 
Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidaemi-
a: A clinical and laboratory study. Haemostasis 1989;19:83-90. 
102. Avellone G, di Garbo V, Cordove R, Raneli G, de Simone R, Bompiani GD. Fibrinolysis in hypertri-
glyceridaemic subjects in response to venous occlusion. Blood Coagulat and Fibrinol 1993;4:429-433. 
103. Kario K, Matsuo T. Lipid-related hemostatic abnormalities in the elderly: imbalance between 
coagulation and fibrinolysis. Atherosclerosis 1993;103:131-138. 
104. Nord0y A, Illingworh DR, Connor WE, Goodnight S. Increased activity of factor VII and factor VII-
phospholipid complex measured using a normotest system in subjects with hyperlipidaemia. Hae-
mostasis 1990;20:65-72. 
105. Saha N, Liu Y, Heng CK, Hong S, Low PS, Tay JSH. Association of factor VII genotype with plasma 
factor VII activity and antigen levels in healthy Indian adults and interaction with triglycerides. 
Arterioscler Thromb 1994;14:1923-1927. 
106. Silveira A, Green F, Karpe F, Blomback M, Humphries S, Hamsten A. Elevated levels of factor VII 
94 
activity in the postprandial state: effect of the factor VII Arg-Gln polymorphism. Thromb Haemost 
1994;72:734-739. 
107. Humphries S, Temple A, Lane A, Green F, Cooper J, Miller G. Low plasma levels of factor VIIc and 
antigen are more strongly associated with the 10 base pair promoter (-323) insertion than the glutamine 
353 variant. Thromb Haemost 1996;75:567-572. 
108. Weintraub MS, Zechner R, Brown A, Eisenberg S, Breslow JL. Dietary polyunsaturated fats of the (0-6 
and CO-3 series reduce postprandial lipoprotein levels: chronic and acute effects of fat saturation on 
postprandial lipoprotein metabolism. J Clin Invest 1988;82:1884-1893. 
109. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: A critical review. J Lipid 
Res 1989;30:785-807. 
110. Connelly JB, Roderick PJ, Cooper JA, Meade TW, Miller GJ. Positive association between self-
reported fatty food consumption and factor VII coagulant activity, a risk factor for coronary heart 
disease, in 4246 middle-aged men. Thromb Haemost 1993;70:250-252. 
111. Hofman A, Grobbee DE, de Jong PTVM, van den Ouwenhand FA. Determinants of disease and 
disability in the elderly: The Rotterdam Elderly Study. Eur J Epidemiol 1991;7:403-422. 
112. Goldbohm RA, van 't Veer P, van den Brandt PA, van 't Hof MA, Brants HAM, Hermus RJJ. 
Reproducibility of a food frequency questionnaire and stability of dietary habits determined from five 
annually repeated measurements. In: van den Brandt P, Bausch-Goldbohm S.A. Prospective cohort 
study on diet and cancer in the Netherlands. Thesis, Maastricht 1993. 
113. Goldbohm RA, van den Brandt PA, Brants HAM, van 't Veer P, Sturmans F, Hermus RJJ. Validation 
of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur J Clin 
Nutr 1994;48:253-265. 
114. NEVO-tabel. Nederlands Voedingstoffenbestand. Voorlichtingsbureau voor de Voeding. Den Haag 
1993. 
115. van Gent CM, van der Voort HA, de Bruyn AM, Klein F. Cholesterol determinations. A comparative 
study of methods with special reference to enzymatic procedures. Clin Chem Acta 1977;75:243-251. 
116. Dixon WJ. BMDP Statistical Software Manual. BMDP Statistical Software, Inc. Los Angeles 1990.117. 
Voedingsraad. Advies Richtlijnen Goede Voeding. Voorlichtingsbureau voor de Voeding. Den Haag, 
1986. 
118. Kushi LH, Lenart EB, Willet WC. Health implications of Mediterranean diets in light of contemporary 
knowledge. I. Plant foods and dairy products. Am J Clin Nutr 1995;61(suppl):1407S-15S. 
119. Assmann G, Cullen P, Heinrich J, Schulte H. Hemostatic variables in the prediction of coronary risk: 
results of the 8 year follow-up of healthy men in the Munster heart study (PROCAM). Isr J Med Sci 
1996;32:364-370. 
120. Mennen LI, Schouten EG, Grobbee DE, Kluft C. Coagulation factor VII, dietary fat and blood lipids: a 
review. Thrombosis and Haemostasis 1996;76:492-499. 
121. Bernardi F, Marchetti G, Pinotti M, Arcieri P, Baroncini C, Papacchini M, Zepponi E, Ursicino N, 
Chiarotti F. Mariani G. Factor VII gene polymorphisms contribute about one third of the factor VII 
level variation in plasma. Arterioscler Thromb Vase Biol 1996;16:72-76. 
122. Avvisati G. Evaluation of a new chromogenic assay for factor VII and its application in patients on oral 
anticoagulant treatment. Br J Haematol 1980;45:343-352. 
123. Droog S, Lakenberg N, Meulenbelt I, de Maat MPM, Huisman LGM, Jie AFH, Slagboom PE. Isolation 
and storage of DNA for population studies. Fibrinolysis 1996; 10 suppl.2:23-24. 
124. de Maat MPM, Green F. de Knijff P, Jespersen J, Kluft C. Factor VII polymorphisms in populations 
95 
References 
with different risk of cardiovascular disease. Arterioscler Thromb Vase Biol (in press). 
125. Cara L, Dubois C, Borel P, Armand M, Senft M, Portugal H, Pauli AM, Bernard PM, Lairon D. 
Effects of oat bran, rice bran, wheat fibre, and wheat germ on portprandial lipemia in healthy adults. 
Am J Clin Nutr 1992;55:81-88. 
126. Hey wood DM, Mansfield MW, Grant PJ. Factor VII gene polymorphisms, factor VII:C levels and 
features of insulin resistance in non-insulin-dependent-diabetes mellitus. Thrombosis and Haemostasis 
1996;75:401-406. 
127. Meilahn E, Ferrell R, Kiss J, Temple A, Green F, Humphries S, Kuller L. Genetic determination of 
coagulation factor VIIc levels among healthy middle-aged women.Thromb Haemost 1995;73:623-625. 
128. Sanders TAB, Miller GJ, de Grassi T, Yahia N. Postprandial activation of coagulant factor VII by long-
chain dietary fatty acids.Thromb Haemost 1996;76:369-371. 
129. Tholstrup T, Andreasen K, Sandstrom B. Acute effect of high-fat meals rich in either stearic or myristic 
acid on hemostatic factors in healthy young men. Am J Clin Nutr 1996;64:168-176. 
130. Miller GJ, Martin JC, Mitropoulos KA, Esnouf MP, Cooper JA, Morrissey JH, Howarth DJ, Tudden-
ham EGD. Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with 
congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency. Blood 
199687:4187-4196. 
131. Silveira A, Karpe F, Johnsson H, Bauer KA, Hamsten A. In vivo demonstration in humans that large 
postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulati-
on pathway. Arterioscler Thromb Vase Biol 1996;16:1333-1339. 
132. Kapur R, Hoffman CJ, Bhushan V, Hultin MB. Postprandial elevation of activated factor VII in young 
adults. Arterioscler Thromb Vase Biol 1996;16:1327-1332. 
133. Feunekes GU, van Staveren WA, de Vries JHM, Burema J, Hautvast JGAJ. Relative and biomarker-
based validity of a food-frequency questionnaire estimating intake of fats and cholesterol. Am J Clin 
Nutr 1993;58:489-496. 
134. Voorlichtingsbureau van de Voeding. Zo eet Nederland 1992. Resultaten van de voedselconsumptiepei-
ling 1992. Voorlichtingsbureau voor de Voeding, Den Haag 1993, pp 89. 
135. Mennen L, de Maat M, Meijer G, Zock P, Grobbee D, Kok F, Kluft C, Schouten E. Factor VII:A 
response on a fat rich meal depends on the R/Q353 polymorphism, but not on fatty acid composition. 
Thromb Haemost 1997;77(suppl):412-413 (abstract). 
136. Meulenbelt I, Droog S, Trommelen GJM, Boomsma DI, Slagboom PE. High-yield noninvasive human 
genomic DNA isolation method for genetic studies in geographically dispersed families and populati-
ons. Am J Hum Genet 1995;57:1252-1254. 
137. Green F, Humphries S. Genetic determinants of arterial thrombosis. Baillieres Clin Haematol 1994;7: 
675-692. 
138. Kelleher CC, Mitropoulos KA, Imeson J, Meade TW, Martin JC, Reeves BEA, Hughes LO. Hageman 
factor and risk of myocardial infarction in middle-aged men. Atherosclerosis 1992;97:67-73. 
139. Moor E, Silveira A, van 't Hooft F, Suontaka AM, Eriksson P, Blomback, Hamsten A. Coagulation 
factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma 
lipoproteins and factor VII genotype. Arterioscler Thromb Vase Biol 1995;15:655-664. 
140. Salomaa V, Rasi V, Pekkanen J, Vahtera E, Jauhiainen M, Vartiainen E, Myllyla G, Ehnholm C. 
Haemostatic factors and prevalent coronary heart disease; the FINRISK Haemostasis Study. Eur Heart J 
1994;15:1293-1299. 
96 
141. Sandset PM, Sirnes PA, Aboldgaard U. Factor VII and extrinsic pathway inhibitor in acute coronary 
disease. Br J Haematol 1989;72:391-396. 
142. Tanaka M, Suzuki A. Hemostatic abnormalities in acute myocardial infarction as detected by specific 
blood markers. Thromb Res 1994;76:289-298. 
143. Vaziri ND, Kennedy SC, Kennedy D, Gonzales E. Coagulation, fibrinolytic, and inhibitory proteins in 
acute myocardial infarction and angina pectoris. Am J Med 1992;93:651-657. 
144. Lane A, Green F, Scarabin PY, Nicaud V, Bara L, Humphries S, Evans A, Luc G, Cambou JP, 
Arveiler D, Cambien F. Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in 
patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a 
strong indicator of MI risk in the ECTIM study. Atherosclerosis 1996;119:119-127. 
145. Lindahl AK, Wildgoos P, Lumsden AB, Allen R, Kelly AB, Harker LA, Hanson SR. Active site-
inhibited factor Vila blocks tissue factor activity and prevents arterial thrombus formation in baboons, 
(abstr.) Circulation 1993;88(Suppl I):I-417. 
146. Constantinides P. Causes of thrombosis in human atherosclerotic arteries. Am J Cardiol 1990;66:37G-
40G. 
147. Davies MJ, Thomas AC. Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic 
death, and crescendo angina. Br Hear J 1985;53:363-373. 
148. Gorlin R, Fuster V, Ambrose JA. Anatomic-physiologic links between acute coronary syndromes. 
Circulation 1986;74:6-9. 
149. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall 
and in the atherosclerotic plaque. Proc natl Acad Sci 1989;86:2839-2843. 
150. Toshi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernandez-Ortiz A, Chesebro JH, Badimon L, 
Nemerson Y, Fuster V, Badimon JJ. Tissue factor modulates the thrombogenicity of human atheroscle-
rotic plaques. Circulation 1997;95:594-599. 
151. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon 
L. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications 
for consequences of plaque rupture. J Am Coll Cardiol 1994;23:1562-1569. 
152. Fuster F, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the 
acute coronary syndromes New Engl J Med 1992;326:212-250. 
153. Hamsten A, de Faire U, Walldius G, Dahlen G, Szamosi A, Landou C, Blomback M, Wiman B. 
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. The Lancet 
1987;2:3-9. 
154. Ott R, Pfeiffer RA. Evidence that activities of coagulation factors VII and X are linked to chromosome 
13(q34). Hum Hered 1984;34:123-126. 
155. Kario K, Narita N, Matsuo T, Kayaba K, Tstsumi A, Matsuo M, Miyata T, Shimada K. Genetic 
determinants of plasma factor VII activity in the Japanese. Thromb Haemost 1995;73:617-622. 
156. Bentzen J, Bladbjerg EM, de Maat MPM, Marckmann P. Plasma factor VII levels are determined by 
polymorphisms in the factor VII gene. Fibrinolysis 1996;10(suppl 2): 17-18. 
157. Marchetti G, Patracchini P, Papacchini M, Ferrati M, Bernardi F. A polymorphism in the 5'region of 
coagulation factor VII gene (F7) caused by an inserted decanucleotide. Hum Genet 1993;90:575-576. 
158. Marchetti G, Gemmati D, Patracchini P, Pinotti M, Bernardi F. PCR detection of a repeat 
polymorphism within the F7 gene. Nucl Acids Res 1991; 19:4570. 
159. Hey wood DM, Ossei-Gerning N, Grant PJ. Association of factor VII:C levels with environmental and 
genetic factors in patients with ischaemic heart disease and coronary atheroma characterised by 
97 
References 
angiography. Thromb Haemost 1996;76:161-165. 
160. Mulcahy D, Keegan J, Cunningham D, Quyyumi A, Crean P, Park A, et al. Circadian variation of total 
ischaemic burden and its alteration with anti-anginal agents. The Lancet 1988;11:755-758. 
161. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, Poole WK, Passamani E, 
Roberts R, Robertson T, Sobel B, Willerson JT, Braunwald E. Circadian variation in the frequency and 
onset of acute myocardial infarction. N Engl J Med 1985;313:1315-1322. 
162. Katan MB, Grundy SM, Willet WC. Beyond low fat diets. N Engl J Med 1997 (in press). 
163. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis 
of 27 trials. Arterioscler Thromb 1992;12:911-919. 
98 
SUMMARY 
Factor VII is a vitamin K-dependent coagulation factor present in the plasma mainly as 
inactive factor VII zymogen. About 1% of factor VII circulates in the activated form: 
FVIIa. When the vessel wall is damaged, tissue factor is released and the inactive factor 
VII zymogen will become rapidly activated. This will eventually lead to the formation of 
fibrin, which together with activated platelets will form a blood clot. The coagulation 
mechanism exists to prevent extensive blood loss during vessel damage. However, when 
the coagulation mechanism is activated in narrowed arteries, this may result in a harmful 
occlusion of a blood vessel. Indeed, several coagulation factors are found to be risk 
indicators for cardiovascular disease. In longitudinal studies it was observed that factor VII 
is a risk indicator for coronary heart disease, and more specifically for fatal events. 
In view of prevention of coronary heart disease knowledge of the determinants of factor 
VII levels is needed. Genetic factors are very important predictors of the factor VII level. 
The Q allele of the R/Q353 polymorphism in the gene coding for factor VII is associated 
with lower levels of total factor VII (FVIIt) as well as activated factor VII (FVIIa). This 
polymorphism is a result of a single base change in the codon for amino acid 353 and 
leads to the replacement of arginine (R) by glutamine (Q). Furthermore, it is known that in 
young and middle-aged people factor VII increases with an increase in dietary fat intake. 
Although the incidence of coronary heart disease increases with increasing age, factor VII 
has not been studied extensively in elderly people. Therefore we investigated the relation 
of diet with factor VII in elderly men and women and evaluated whether this relation 
differs between the genotypes of the R/Q353 polymorphism. 
In Chapter 2 a review is given of all recent studies on the relation of factor VII with 
dietary fat and blood lipids. The studies presented included mostly young and middle-aged 
males. First the different methods to measure factor VII are described and examples of 
mechanisms behind the relation of factor VII and dietary fat are given. Factor VII 
coagulant activity (FVII:C) seems to increase after a fat-rich diet as well as postprandially 
after a fat-rich meal. The chronic effects of a fat-rich diet on fasting FVIIt are less clear, 
while FVIIt does not respond to a fat-rich meal. For both FVII:C and FVIIt it seems that 
the type of fat has no influence on the response. Results from cross-sectional studies show 
that serum-triglycerides and total-cholesterol are associated with FVILC and with FVIIt. 
This association is, however, not always seen in studies on the chronic effects of dietary 
fat on factor VII. Finally the association of factor VII with blood lipids may vary across 
genotypes of the R/Q353 polymorphism. This was also shown for the association of factor 
VII with dietary fat in a small study among male post-infarction patients. 
It seems quite clear that the amount of fat intake is important; high-fat meals increase 
factor VII. Whether fat composition is of any importance remains to be clarified. 
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We used the cross-sectional data from the Rotterdam Study, a population-based study 
among 7,983 people older than 55 years, to study the association of FVILC and FVIIt 
with diet (Chapter 3). Subjects were excluded when they used anticoagulants, had 
diabetes mellitus, had a myocardial infarction in the year before the investigation and 
when no dietary data or blood samples taken with minimal stasis were available. In total 
1730 women and 1277 men were included in the cross-sectional data analysis. 
In this population FVILC was positively associated with total fat intake in women only 
(8=0.1 %/g, 95%confidence interval (CI):0.01,0.20). Saturated fat intake was associated 
with FVILC in women (3=0.18 %/g, CL-0.001,0.36) and in men (6=0.11 %/g, CL-
0.06,0.27). Monounsaturated fat was positively related to FVILC in women (6=0.17 %/g, 
CL-0.05,0.39), while polyunsaturated fat was inversely associated with FVILC in men (6=-
0.15 %/g, CL-0.33,0.03). Fibre intake was inversely associated with FVILC in both 
women (6=-0.36 %/g, CL-0.63,-0.09) and men (6=-0.31 %/g, CL-0.57,-0.06). This means 
for example that if the fibre intake in women would increase with 10 g, FVILC would 
decrease with 3.6%. The results of this cross-sectional study suggest that FVILC may be 
affected by a low-fat and/or a high-fibre diet at old age. 
To look further into these relations the study population was divided into quintiles of the 
FVILC distribution (Chapter 4). For the subjects in the extreme quintiles (upper and 
lower) FVIIt, serum-triglycerides and the genotype for the R/Q353 polymorphism were 
determined. The lowest quintile comprised 538 subjects and the highest 575. Of these 
subjects 858 were homozygous for the R allele, 268 were heterozygous and 32 were 
homozygous for the Q allele. FVILC was 35% lower (80.6 % pooled plasma (PP) vs 
125.3 %PP) and FVIIt 48% (49.6 %PP vs 95.7 %PP) in individuals with the QQ genotype 
compared to those with the RR genotype. The FVILC and FVIIt levels for those with the 
RQ genotype were intermediate. 
In this subpopulation of the two extreme quintiles FVILC was again positively associated 
with saturated fat intake and inversely with fibre and protein, while FVIIt was only 
inversely associated with fibre. As the group of subjects homozygous for the Q allele was 
too small for further meaningful analyses, it was combined with the heterozygotes. When 
subjects were analyzed by genotype group separately, the association of dietary fibre with 
FVILC was clearly stronger in subjects homozygous for the R allele (6=-0.76 %PP, CL-
1,23,-0.29), compared to those carrying the Q allele (6=-0.19 %PP, CL-0.97,0.59). Similar 
results were found for FVIIt. The association of FVILC with protein was only present in 
those with the RR genotype and not in those with the RQ or QQ genotype. The same was 
true for the association of FVIIt with saturated fat. The association of FVILC with 
saturated fat however was positive in those homozygous for the R allele, while it was 
inverse in those carrying the Q allele. In elderly people a high saturated fat/low-fibre diet 
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may increase the risk of a coronary event through increased factor VII levels. This may be 
especially important in subjects with the RR genotype. 
Similar analyses were carried out for the association of FVILC and FVIIt with serum-
triglycerides Chapter 5). In women triglycerides were positively associated with FVIIt and 
FVILC. These associations were stronger in women homozygous for the R allele (FVIIt: 
B=11.7, CI: 9.6-13.8; FVILC: 6=12.5, CL9.5-15.5) compared to women carrying the Q 
allele (FVIIt: 6=7.9, CI: 4.6-11.2; FVILC 6=6.4, CI: 1.4-11.4). In men the associations of 
FVIIt and FVILC with serum-triglycerides were weaker (FVIIt: 6=5.9, CL4.1-7.7; FVILC: 
6=8.7, CL6.2-11.2). There was no difference in this association between the genotype 
groups. The R/Q353 polymorphism modifies the association between factor VII and 
triglyceride status, especially in elderly women. This indicates that both genetic factors 
and life style elements are important for determining a persons coagulable state. 
The results of the cross-sectional study indicate that the influence of dietary fat on factor 
VII may be different between elderly women homozygous for the R allele and women 
carrying the Q allele and that serum-triglycerides may be an intermediate factor. Therefore 
we hypothesized that the response of factor VII after a fat-rich meal is higher in elderly 
women with the RR genotype and that this response is associated with a postprandial 
increase in serum-triglycerides. We tested this hypothesis in an intervention trial among 91 
elderly women who were selected on their genotype for the R/Q353 polymorphism. 
Furthermore it was tested whether the factor VII response depended on the fatty acid 
composition of the fat-rich meal. 
Fifty six women with the RR genotype and 35 women with the RQ or QQ genotype were 
included in the study (Chapter 6). The women received on separate days four different 
fat-rich breakfasts (50 energy % of fat) and a control breakfast (1.5 en% fat) (cross-over). 
The fat-rich breakfasts differed in fatty acid composition: one rich in palmitic acid, one in 
stearic acid, the other two in linoleic and linolenic acid one with a ratio 3:1 and another 
with a ratio of 15:1. At 8.00 AM before the breakfast (fasting) and at 1.00 and 3.00 PM 
blood samples were taken, in which FVIIa and serum-triglycerides were measured. 
When the data of all subjects were combined and analyzed as a total group the FVIIa 
response to the fat-rich meals ranged from 14.9 IU/mL (CI: 10.6,19.2) on the stearic meal 
to 21.1 IU/mL (CI: 16.6,25.6) on the linoleic/linolenic 15:1 meal at 3.00 PM. The average 
responses on the fat-rich meals were not clearly different from each other. After the 
control breakfast FVIIa decreased with 6.3 IU/mL (CI: 3.9,8.7) at 1.00 PM and with 8.7 
IU/mL (CI: 6.3,11.1) at 3.00 PM. The triglyceride response was lower after both 
linoleic/linolenic rich breakfasts compared to the palmitic and stearic breakfast (p<0.05). 
The response of serum-triglycerides was not associated with the FVIIa response at any of 
the blood sampling occasions. This suggests that in elderly women the FVIIa response to a 
fat-rich meal is not dependent on the fatty acid composition, and that this response is not 
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mediated by a postprandial increase in triglycerides. 
When the data were analyzed for the two genotype groups separately again no difference 
in FVIIa response between the different fat-rich meals could be observed (Chapter 7). 
Therefore the mean FVIIa response on the four fat-rich meals was taken to evaluate the 
differences in FVIIa response between the genotype groups. The mean absolute combined 
response to all four test breakfasts was 37.0 IU/mL in those with the RR genotype and 
16.1 IU/mL in those carrying the Q allele (p<0.001 for difference). Likewise, the FVIIa 
response relative to the fasting FVIIa level was significantly higher in women homozygous 
for the R allele (42%) compared to the women carrying the Q allele (32%). In elderly 
women the response of FVIIa to a fat-rich meal clearly depends on the genotype for the 
R/Q353 polymorphism, but not on the fatty acid composition of the meal. One mechanism 
to explain these results is that the charge change ensuing from the substitution of the 
positively charged arginine by the neutral glutamine affects the interaction of factor VII 
with lipid surfaces. 
In conclusion the results from our cross-sectional study show associations of dietary fibre, 
saturated fat and protein with FVILC and of fibre with FVIIt. These associations were 
weaker or absent in elderly men and women carrying the Q allele compared to those 
homozygous for the R allele. Also, the association of serum-triglycerides with FVILC and 
FVIIt varied across genotypes of the R/Q353 polymorphism. In our intervention study we 
observed a profound increase of FVIIa after a fat-rich meal, which was twice as high in 
elderly women with the RR genotype, compared to women with the RQ or QQ genotype. 
This increase did not depend on the type of fat consumed and was not associated with an 
increase in serum-triglycerides. This indicates that in view of prevention of a coronary 
event, a diet with a low to moderate fat intake may be recommendable, particularly in 
elderly women homozygous for the R allele. 
In Chapter 8 studies on factor VII and coronary heart disease are summarized. From 
prospective studies it seems evident that factor VILC is associated with fatal coronary 
events, but results from case-control studies are inconclusive. It seems likely that not 
FVIIt, but FVIIa is important in the outcome of a coronary event. Additionally the 
hypotheses explaining the association of factor VII with dietary fat are discussed. The 
exact mechanisms behind the effect of dietary fat on factor VII remain to be clarified. 
Three polymorphisms of the factor VII locus, which are associated with factor VII levels 
are described. It seems clear that polymorphisms in the gene coding for factor VII 
influence factor VII directly but also indirectly through effects on the relation of diet and 
blood lipids with factor VII. Finally suggestions for practical implications and future 
research are made. The fact that total fat intake is responsible for changes in factor VII 
rather than fat type, should be included in the discussion concerning the validity of the 
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total fat intake recommendations to lower the risk of cardiovascular disease. In future 
studies on the relation of factor VII and coronary heart disease measurement of FVIIa and 
the genotype of the functional polymorphism should be included. Polymorphisms which 
influence the fatty acid metabolism should be investigated in intervention studies on factor 
VII and dietary fat and intervention studies are needed to confirm the inverse association 
between factor VII and dietary fibre. 
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Factor VII is een vitamine K-afhankelijke stollingsfactor die in het plasma voornamelijk 
aanwezig is in de vorm van het inactieve factor VII zymogeen. Ongeveer 1% van het in 
het plasma aanwezige factor VII komt voor in de geactiveerde vorm: FVIIa. Tijdens 
beschadiging van een bloedvat komt tissue factor vrij uit de vaatwand, dat in staat is om 
factor VII snel te activeren. Activatie van factor VII zal dan uiteindelijk leiden tot de 
vorming van fibrine, dat tezamen met geactiveerde bloedplaatjes een stolsel vormt. Het 
doel van dit stollingsmechanisme is het voorkomen van extreem bloedverlies tijdens 
schade aan de vaatwand. Als dit mechanisme echter te sterk geactiveerd wordt in 
vernauwde bloedvaten kunnen stolsels optreden die het vaatlumen kunnen afsluiten. Van 
verschillende stollingsfactoren is bekend dat ze een risicoindicator zijn voor hart- en 
vaatziekten. Zo is uit longitudinale studies gebleken dat factor VII een risicoindicator 
vormt voor coronaire hartziekten en met name voor fatale gevallen daarvan. 
In het kader van preventie van hart- en vaatziekten is het nodig meer te weten van de 
determinanten van het niveau van factor VII. Genetisch factoren zijn zeer belangrijke 
voorspellers van het factor VII niveau. Zo houdt het Q allel van het R/Q353 polymorfisme 
in het gen dat codeert voor factor VII verband met lagere niveaus van totaal factor VII 
(FVIIt) en geactiveerd factor VII (FVIIa). Dit polymorfisme is een gevolg van een 
verwisseling van een basepaar in het codon voor aminozuur 353 en leidt tot een 
vervanging van arginine (R) door glutamine (Q). Het is bekend dat bij mensen van jonge 
en middelbare leeftijd factor VII sterk stijgt bij een verhoging van de vetinneming. 
Alhoewel de kans op het krijgen van symptomatische coronaire hartziekte groter wordt 
naar mate men ouder wordt, is factor VII nog niet uitgebreid onderzocht bij oudere 
mensen. Daarom hebben wij de relatie tussen factor VII en voeding onderzocht bij oudere 
mannen en vrouwen, en hebben we gekeken of deze relatie bei'nvloed wordt door het 
R/Q353 polymorfisme. 
In hoofdstuk 2 worden alle recente onderzoeken naar factor VII en voedingsvet en 
bloedlipiden beschreven. De deelnemers in deze onderzoeken waren met name mannen 
van jonge en middelbare leeftijd. Als eerste worden de verschillende methoden om factor 
VII te meten weergegeven en worden mogelijke mechanismen die de relatie tussen factor 
VII en voedingsvet kunnen verklaren besproken. Uit de studies blijkt dat factor VII 
coagulant activiteit (FVII:C) zowel na een vetrijk dieet verhoogd is als direct na een 
vetrijke maaltijd. De chronische effecten van een vetrijk dieet op FVIIt zijn minder 
eenduidig, maar FVIIt reageert in ieder geval niet acuut op een vetrijke maaltijd. Voor 
zowel FVII:C als FVIIt geldt dat het soort vet geen invloed heeft op de respons op lange 
en korte termijn. Uit cross-sectionele onderzoeken blijkt dat serum-triglyceriden en totaal 
cholesterol samenhangen met FVII:C en FVIIt. Dit verband wordt echter niet 
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waargenomen in de meeste interventie-onderzoeken naar lange termijn effecten van 
vetinneming op factor VII. Tenslotte lijkt de associatie van factor VII met bloedlipiden te 
varieren tussen de genotypen van het R/Q353 polymorfisme. Een klein onderzoek bij 
mannelijke post-infarct patienten liet dezelfde variatie zien voor het acute effect van een 
vetrijke maaltijd op factor VII. 
De cross-sectionele data van de Rotterdam Study, een prospectief onderzoek onder 7.983 
mensen ouder dan 55 jaar, zijn gebruikt om het verband van FVILC en FVIIt met voeding 
te onderzoeken (hoofdstuk 3). Deelnemers werden uitgesloten als ze anticoagulantia 
gebruikten, een hartinfarct hadden gehad in het jaar voorafgaande aan het onderzoek, 
diabetes mellitus hadden of als geen bloedmonster of voedingsdata beschikbaar waren. In 
totaal werden 1730 vrouwen en 1277 mannen geselecteerd voor het onderzoek. 
Alleen bij vrouwen was FVILC positief geassocieerd met totale vetinneming (6=0.1 %/g, 
95%betrouwbaarheidsinterval (BI):0.01,0.20). Inneming van verzadigd vet hield zowel bij 
vrouwen (6=0.18 %/g, BI:-0.001,0.36) als bij mannen (6=0.11 %/g, BI:-0.06,0.27) verband 
met FVILC. Enkelvoudig onverzadigd vet was positief gerelateerd aan FVILC in vrouwen 
(6=0.17 %/g, BL-0.05,0.39), terwijl meervoudig onverzadigd vet invers gerelateerd was 
aan FVILC in mannen (6=-0.15 %/g, BL-O.33,0.03). Inneming van voedingsvezel was 
invers geassocieerd met FVILC in vrouwen (6=-0.36 %/g, BI:-0.63,-0.09) en in mannen 
(6=-0.31 %/g, BL-0.57,-0.06). Dit betekent bijvoorbeeld dat een verhoging van de 
vezelinneming met 10 g bij oudere vrouwen zou kunnen leiden tot een verlaging van 
FVILC met 3.6%. De resultaten van dit cross-sectionele onderzoek geven aan dat FVILC 
mogelijk ook op oudere leeftijd bei'nvloed kan worden door een vetarme en/of vezelrijke 
voeding. 
Om het effect van het genotype op deze relaties nader te onderzoeken is de studiepopulatie 
opgesplitst in quintielen van de FVILC verdeling (hoofdstuk 4). In bloedmonsters van de 
deelnemers uit de twee uiterste quintielen (de hoogste en de laagste) zijn FVIIt, serum-
triglyceriden en het genotype voor het R/Q353 polymorfisme bepaald. In het laagste 
quintiel bevonden zich 538 deelnemers en in het hoogste 575. In de totale groep waren 
858 deelnemers homozygoot voor het R allel, 268 heterozygoot, en 32 homozygoot voor 
het Q allel. FVILC was 35% lager (80.6 % pooled plasma (PP) vs 125.3 %PP) en FVIIt 
was 48% later (49.6 %PP vs 95.7 %PP) in personen met het QQ genotype in vergelijking 
met personen die het RR genotype hadden. Het niveau van FVILC en FVIIt van de 
heterozygote personen lag daar tussenin. 
In deze subpopulatie van extreme quintielen hield FVILC eveneens positief verband met 
de inneming van verzadigd vet en invers met voedingsvezel en eiwit, terwijl FVIIt alleen 
invers geassocieerd was met voedingsvezel. Omdat er voor verdere zinvolle data-analyse te 
weinig mensen waren met het QQ genotype is deze groep samengevoegd met de groep 
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heterozygoten. Wanneer de gegevens apart per genotypegroep werden geanalyseerd bleek 
het verband van FVILC met voedingsvezel duidelijk sterker te zijn in personen die 
homozygoot zijn voor het R allel (B=-0.76 %PP, BI:-1,23,-0.29), in vergelijking met de 
dragers van het Q allel (6=-0.19 %PP, BI:-0.97,0.59). Vergelijkbare resultaten werden 
gevonden voor FVIIt. Het verband van FVILC met eiwit was alleen aanwezig onder de 
homozygoten voor het R allel, en niet onder de dragers van het Q allel. Hetzelfde gold 
voor de relatie tussen FVIIt en verzadigd vet. FVILC was echter positief gecorreleerd aan 
verzadigd vet in personen met het RR genotype en invers in personen met het RQ of QQ 
genotype. Een voeding rijk aan verzadigd vet en arm aan vezel kan in oudere mensen het 
risico op coronaire hartziekten vergroten via een verhoging van het factor VII niveau. Dit 
zal vooral van belang zijn in personen met het RR genotype. 
Dezelfde data-analyse is in deze subpopulatie uitgevoerd voor het verband van FVILC en 
FVIIt met serum-triglyceriden (hoofdstuk 5). FVIIt en FVILC waren positief gerelateerd 
aan serum-triglyceriden bij vrouwen. Dit verband was sterker bij vrouwen die homozygoot 
waren voor het R allel (FVIIt: 6=11.7, BI: 9.6-13.8; FVILC: 13=12.5, BL9.5-15.5) in 
vergelijking met vrouwen die het Q allel dragen (FVIIt: 6=7.9, BI: 4.6-11.2; FVILC 6=6.4, 
BI: 1.4-11.4). De associatie van FVILt en FVILC met serum-triglyceriden bij mannen was 
zwakker (FVIIt: 6=5.9, BL4.1-7.7; FVILC: 6=8.7, BL6.2-11.2). Er was bij mannen geen 
verschil tussen de genotypegroepen in het verband van FVIIt en FVILC met serum-
triglyceriden. Het blijkt dus dat het R/Q353 polymorfisme de associatie tussen factor VII 
en triglyceriden modificeert. Dit geeft aan dat zowel genetische factoren als 
omgevingsfactoren belangrijk zijn bij de bepaling van iemands stollingsstatus. 
De resultaten van het cross-sectionele onderzoek geven aan dat de invloed van voedingsvet 
op factor VII verschillend kan zijn voor oudere vrouwen die homozygoot zijn voor het R 
allel en vrouwen die het Q allel dragen en dat het serum-triglyceriden niveau een 
intermediair kan zijn. Naar aanleiding hiervan is de hypothese opgesteld dat de respons 
van factor VII op een vetrijke maaltijd hoger is bij vrouwen met het RR genotype en dat 
deze respons verband houdt met een postprandiale verhoging in serum-triglyceriden. We 
hebben deze hypothese getoetst in een interventie-onderzoek bij 91 oudere vrouwen die 
geselecteerd waren op het genotype van het R/Q353 polymorfisme. Bovendien is 
onderzocht of de factor VII respons afhankelijk is van de vetzuursamenstelling van de 
maaltijd. 
Vijfenzestig vrouwen met het RR genotype en 35 vrouwen met het RQ of QQ genotype 
zijn voor dit onderzoek geselecteerd (hoofdstuk 6). De vrouwen kregen vier vet-rijke 
ontbijten (50 energie% vet) en een controle-ontbijt (1.5 en%) op verschillende dagen 
(cross-over). De vetrijke ontbijten verschilden in vetzuursamenstelling: 1 was rijk aan 
palmitinezuur, 1 rijk in stearinezuur, de andere twee waren rijk aan linol- en linoleenzuur, 
1 met een ratio 3:1 en 1 met een ratio 15:1. Om 08.00 uur werd voor het ontbijt nuchter 
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bloed afgenomen en om 13.00 en om 15.00 uur werd opnieuw bloed afgenomen. In deze 
bloedmonsters werd FVIIa en serum-triglyceriden bepaald. 
In eerste instantie zijn de gegevens van alle deelnemers gezamenlijk geanalyseerd. De 
FVIIa respons op de vetrijke ontbijten liep van 14.9 IU/mL (BI: 10.6,19.2) na het 
stearinerijke ontbijt tot 21.1 IU/mL (BI: 16.6,25.6) na het linol/linoleenzuur rijke ontbijt 
met ratio 15:1 om 15.00 uur. De effecten van de vetrijke ontbijten waren niet verschillend 
van elkaar. Na het controle ontbijt was FVIIa met 6.3 IU/mL (BI: 3.9,8.7) gedaald om 
13.00 uur en met 8.7 IU/mL (BI: 6.3,11.1) om 15.00 uur. De triglyceridenrespons was 
lager na beide linol/linoleenzuurrijke ontbijten dan na de palmitine- en stearinezuurrijke 
ontbijten (p<0.05). De respons van serum-triglyceriden hield op geen enkel moment van 
bloedafname verband met de respons van FVIIa. Deze resultaten suggereren dat de FVIIa 
respons op een vetrijke maaltijd in oudere vrouwen niet afhankelijk is van de 
vetzuursamenstelling van de maaltijd en dat deze respons niet gemedieerd wordt door een 
postprandiale stijging in serum-triglyceriden. 
Deze gegevens zijn opnieuw geanalyseerd, maar nu voor de beide genotypegroepen apart 
(hoofdstuk 7). Er was in geen van de groepen een duidelijk verschil te zien in de respons 
tussen de vier vetrijke ontbijten. Daarom zijn de resultaten van de vetrijke ontbijten 
gecombineerd om de verschillen in FVIIa respons tussen de genotypegroepen te 
vergelijken. De gemiddelde absolute respons op de vier vetrijke ontbijten was 37.0 IU/mL 
voor deelnemers met het RR genotype en 16.1 IU/mL voor deelnemers met het RQ of QQ 
genotype (p<0.001 voor verschil). Bovendien was de relatieve FVIIa respons (gecorrigeerd 
voor nuchter FVIIa niveau) significant hoger bij vrouwen homozygoot voor het R allel 
(42%) dan bij dragers van het Q allel (32%). Het lijkt duidelijk dat de respons van FVIIa 
op een vetrijke maaltijd in oudere vrouwen wel afhangt van het genotype voor het R/Q353 
polymorfisme, maar niet van de vetzuursamenstelling van het ontbijt. Het kan zijn dat de 
verandering van lading, als gevolg van de uitwisseling van het positief geladen arginine 
met het neutrale glutamine, invloed heeft op de interactie tussen factor VII en 
vetoppervlakken (hoofdstuk 7). 
Concluderend lijken de resultaten van het cross-sectionele onderzoek erop te wijzen dat 
voedingsvezel, verzadigd vet en eiwit verband houden met FVII:C en FVIIt en dat deze 
verbanden zwakker of zelfs afwezig zijn bij oudere mensen die het Q allel dragen in 
vergelijking met ouderen homozygoot voor het R allel. Ditzelfde geldt voor het verband 
van serum-triglyceriden met FVII:C en FVIIt. Uit ons interventie-onderzoek is gebleken 
dat FVIIa sterk verhoogd is na een vetrijke maaltijd, maar dat deze verhoging twee keer 
zo hoog is bij oudere vrouwen met het RR genotype in vergelijking met vrouwen die het 
Q allel dragen. Het type vet in de maaltijd lijkt geen invloed te hebben op deze verhoging. 
Dit geeft aan dat in het kader van preventie van coronaire hartziekten een voeding met een 
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laag tot gemiddeld vetgehalte is mogelijk aan te raden voor oudere vrouwen die 
homozygoot zijn voor het R allel. 
In hoofdstuk 8 worden studies naar de relatie tussen factor VII en coronaire hartziekten 
samengevat. Uit prospectieve studies lijkt het duidelijk dat FVII:C geassocieerd is met 
coronaire hartziekten, maar resultaten van case-control studies zijn niet eenduidig. Het lijkt 
erop dat niet FVIIt, maar FVIIa belangrijk is bij coronaire hartziekten. Tevens worden de 
mechanismen die het effect van voedingsvet op factor VII zouden kunnen verklaren 
besproken. De exacte werking van de mechanismen achter het effect van voedingsvet op 
factor VII moet nog nader onderzocht worden. De drie polymorfismen in het factor VII 
gen die verband houden met factor VII niveaus worden kort beschreven. Het lijkt evident 
dat de polymorfismen in het factor VII gen factor VII niet alleen direct bei'nvloeden, maar 
ook indirect via effecten op de relatie van voeding en bloedlipiden met factor VII. 
Tenslotte worden implicaties en aanbevelingen voor vervolgonderzoek gegeven. Het feit 
dat factor VII met name bei'nvloed wordt door de totale vetinneming en niet door het type 
vet, zou betrokken moeten worden in de discussie rond de vraag of de aanbevelingen voor 
totaal vet nog wel valide zijn. In toekomstig onderzoek naar de relatie tussen factor VII en 
coronaire hartziekten zouden FVIIa en het genotype van het functionele polymorfisme 
gemeten moeten worden. Polymorfismen die betrokken zijn bij het vetmetabolisme zouden 
betrokken moeten worden bij interventiestudies naar factor VII en voedingsvet. Als laatste 
zijn interventiestudies nodig die de relatie tussen factor VII en voedingsvezel bevestigen. 
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